query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly2.cif.gz_B Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.204	299	207	7	305	1	261	1.183E-15	495
LOKIASV2_3079_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	0.192	300	210	11	310	5	265	1.481E-15	485
LOKIASV2_3079_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	0.202	298	205	7	304	1	258	3.628E-15	480
LOKIASV2_3079_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.199	299	209	7	305	1	262	2.592E-15	475
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2 Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.198	295	201	11	305	4	254	3.067E-15	471
LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly1.cif.gz_A Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.206	298	207	7	304	1	262	9.944E-15	462
LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.201	298	201	7	304	1	252	2.060E-14	450
LOKIASV2_3079_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	0.201	291	202	16	306	2	255	2.883E-14	445
LOKIASV2_3079_ESMFold_hypothetical_protein	5l4q-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5l4q-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.165	311	230	5	315	3	279	7.948E-15	432
LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.205	298	204	7	304	1	257	4.772E-14	426
LOKIASV2_3079_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.197	299	215	7	305	3	271	1.948E-14	424
LOKIASV2_3079_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 5)	0.203	300	206	7	306	3	262	1.948E-14	417
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.169	308	216	3	310	1	261	7.854E-13	416
LOKIASV2_3079_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A Crystal Structure of M. tuberculosis PknB Leu33Asp/Val222Asp double mutant in complex with ADP	0.192	301	208	6	306	2	259	9.347E-14	411
LOKIASV2_3079_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.165	311	240	5	315	7	294	2.883E-14	411
LOKIASV2_3079_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.158	312	243	4	315	1	290	2.883E-14	410
LOKIASV2_3079_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	0.205	296	204	16	311	2	259	3.205E-13	409
LOKIASV2_3079_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.161	312	241	4	315	1	288	2.437E-14	409
LOKIASV2_3079_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.164	303	233	4	306	1	280	7.471E-14	404
LOKIASV2_3079_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.174	303	200	1	303	1	243	8.786E-13	403
LOKIASV2_3079_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 2)	0.187	304	212	3	306	1	262	7.901E-14	403
LOKIASV2_3079_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	0.200	300	205	7	306	1	257	8.356E-14	401
LOKIASV2_3079_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	0.163	302	206	5	306	5	251	1.936E-13	399
LOKIASV2_3079_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 6)	0.187	296	206	16	311	11	264	7.901E-14	399
LOKIASV2_3079_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.175	302	205	5	306	3	251	2.422E-13	394
LOKIASV2_3079_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.193	289	206	16	304	10	265	3.224E-14	391
LOKIASV2_3079_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	0.177	302	208	5	306	4	257	2.290E-13	390
LOKIASV2_3079_ESMFold_hypothetical_protein	7lvh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7lvh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.170	313	233	4	316	1	282	7.064E-14	390
LOKIASV2_3079_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.185	300	212	7	306	1	261	3.585E-13	389
LOKIASV2_3079_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.173	302	203	2	303	1	246	1.820E-12	387
LOKIASV2_3079_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	0.196	291	208	16	306	3	262	1.637E-13	385
LOKIASV2_3079_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.196	300	219	7	306	2	274	1.936E-13	384
LOKIASV2_3079_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.210	303	205	8	310	4	263	1.538E-12	379
LOKIASV2_3079_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	0.169	302	240	5	306	3	292	4.772E-14	379
LOKIASV2_3079_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	0.165	302	204	5	306	3	247	1.163E-12	378
LOKIASV2_3079_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.174	305	207	1	305	1	252	6.600E-12	377
LOKIASV2_3079_ESMFold_hypothetical_protein	5l4q-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5l4q-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	0.169	311	233	5	315	3	283	2.048E-13	377
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.185	308	209	3	310	1	258	5.275E-12	376
LOKIASV2_3079_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.167	303	202	1	303	1	244	5.579E-12	375
LOKIASV2_3079_ESMFold_hypothetical_protein	5ikw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	0.167	310	240	7	316	1	289	1.308E-13	373
LOKIASV2_3079_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	0.171	302	200	2	303	1	242	7.383E-12	369
LOKIASV2_3079_ESMFold_hypothetical_protein	2buj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2buj-assembly1.cif.gz_A Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.161	302	237	3	304	3	285	3.186E-12	364
LOKIASV2_3079_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	0.177	296	226	16	311	8	283	1.455E-12	363
LOKIASV2_3079_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.177	302	205	5	306	3	252	4.716E-12	361
LOKIASV2_3079_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	0.164	306	209	2	307	1	251	2.394E-11	360
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.173	295	208	16	310	11	263	1.222E-11	359
LOKIASV2_3079_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	0.173	302	237	5	306	6	292	6.639E-13	357
LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.179	306	218	5	310	6	271	5.579E-12	355
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.170	308	212	3	310	1	257	5.244E-11	351
LOKIASV2_3079_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.169	302	231	3	304	4	282	3.370E-12	351
LOKIASV2_3079_ESMFold_hypothetical_protein	7f3g-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7f3g-assembly1.cif.gz_B Crystal structure of DCLK1 kinase domain in complex with ruxolitinib	0.188	288	205	16	303	8	261	3.370E-12	349
LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.173	306	219	5	310	3	268	1.222E-11	349
LOKIASV2_3079_ESMFold_hypothetical_protein	5jzj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5jzj-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with AMPPN	0.174	285	207	16	300	17	267	1.033E-11	348
LOKIASV2_3079_ESMFold_hypothetical_protein	5jzj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5jzj-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with AMPPN	0.170	285	206	16	300	9	257	6.241E-12	345
LOKIASV2_3079_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	LOKIASV2_3079_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.206	298	202	16	313	10	264	5.901E-12	345
LOKIASV2_3079_ESMFold_hypothetical_protein	7kx6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7kx6-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with XMD8-85	0.184	285	199	16	300	10	254	1.711E-11	344
LOKIASV2_3079_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.171	285	211	16	300	8	263	2.140E-11	343
LOKIASV2_3079_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one	0.208	293	207	16	308	2	263	7.383E-12	342
LOKIASV2_3079_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.169	297	217	16	312	5	266	3.186E-12	341
LOKIASV2_3079_ESMFold_hypothetical_protein	5jzn-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5jzn-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with NVP-TAE684	0.175	285	207	16	300	11	262	1.617E-11	340
LOKIASV2_3079_ESMFold_hypothetical_protein	5jzn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5jzn-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with NVP-TAE684	0.170	285	209	16	300	12	264	2.140E-11	338
LOKIASV2_3079_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3	0.174	284	208	16	299	5	257	8.734E-12	337
LOKIASV2_3079_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.166	291	214	16	306	10	266	1.093E-11	336
LOKIASV2_3079_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A Structure of the Catalytic Domain of Human Polo-like Kinase 1	0.158	313	235	2	314	1	280	7.339E-11	335
LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.168	309	220	2	310	1	265	2.140E-11	334
LOKIASV2_3079_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.158	284	234	16	299	3	281	3.770E-12	334
LOKIASV2_3079_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.161	298	242	16	313	4	292	5.901E-12	334
LOKIASV2_3079_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.137	330	267	1	310	2	331	5.579E-12	334
LOKIASV2_3079_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.146	297	231	16	312	7	277	1.156E-11	333
LOKIASV2_3079_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.166	288	217	16	303	5	265	4.459E-12	332
LOKIASV2_3079_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	0.135	346	259	3	302	4	349	6.639E-13	332
LOKIASV2_3079_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.167	288	213	16	303	5	261	1.033E-11	331
LOKIASV2_3079_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	0.184	311	224	3	313	1	276	2.394E-11	331
LOKIASV2_3079_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.167	285	212	16	300	4	259	2.140E-11	331
LOKIASV2_3079_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	0.163	296	246	9	304	1	295	9.827E-13	331
LOKIASV2_3079_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.166	297	215	16	312	5	263	8.258E-12	330
LOKIASV2_3079_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	0.148	297	227	16	312	9	275	2.263E-11	330
LOKIASV2_3079_ESMFold_hypothetical_protein	3eh9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3eh9-assembly1.cif.gz_A Crystal structure of death associated protein kinase complexed with ADP	0.125	297	235	4	300	1	269	8.209E-11	328
LOKIASV2_3079_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	0.128	297	234	4	300	1	269	1.520E-10	327
LOKIASV2_3079_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.136	347	258	3	302	4	350	1.099E-12	327
LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.141	288	222	16	303	7	265	4.959E-11	326
LOKIASV2_3079_ESMFold_hypothetical_protein	7kl2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7kl2-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B(S1303D)	0.150	288	221	16	303	7	267	1.293E-11	326
LOKIASV2_3079_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A Cryptosporidium parvum calcium dependent protein kinase cgd7_1840	0.158	288	216	16	303	26	282	8.258E-12	326
LOKIASV2_3079_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	0.145	305	245	16	320	12	298	1.027E-10	326
LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.136	287	223	16	302	7	265	5.546E-11	325
LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	0.150	285	222	16	300	15	276	6.981E-12	325
LOKIASV2_3079_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.172	288	209	16	303	9	261	9.769E-12	324
LOKIASV2_3079_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	LOKIASV2_3079_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	0.166	283	230	16	298	4	280	8.734E-12	324
LOKIASV2_3079_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A Structure of RIP2K(D146N) with bound Staurosporine	0.143	292	221	16	307	14	272	2.678E-11	323
LOKIASV2_3079_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	0.197	294	202	16	309	5	257	5.866E-11	321
LOKIASV2_3079_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor	0.164	298	240	16	313	4	291	6.600E-12	321
LOKIASV2_3079_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	0.180	296	226	16	311	8	283	3.543E-11	321
LOKIASV2_3079_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.143	322	259	1	303	2	323	1.446E-11	321
LOKIASV2_3079_ESMFold_hypothetical_protein	5ehy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ehy-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.198	296	201	7	302	2	253	3.747E-11	320
LOKIASV2_3079_ESMFold_hypothetical_protein	2wmb-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2wmb-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.183	288	208	16	303	5	259	1.156E-11	320
LOKIASV2_3079_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with purpurin	0.127	297	230	4	300	1	264	1.027E-10	320
LOKIASV2_3079_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.163	285	213	16	300	8	263	2.140E-11	320
LOKIASV2_3079_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.162	296	244	16	311	7	298	8.258E-12	320
LOKIASV2_3079_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.137	345	257	3	301	4	348	4.216E-12	320
LOKIASV2_3079_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.146	297	231	16	312	2	272	1.711E-11	320
LOKIASV2_3079_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	0.163	284	203	16	299	9	252	5.213E-10	319
LOKIASV2_3079_ESMFold_hypothetical_protein	3dog-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3dog-assembly1.cif.gz_C Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1	0.172	288	210	16	303	5	259	7.383E-12	319
LOKIASV2_3079_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	0.155	292	224	16	307	14	279	2.832E-11	319
LOKIASV2_3079_ESMFold_hypothetical_protein	3gu6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3gu6-assembly1.cif.gz_A Crystal structure of DAPKQ23V-ADP	0.130	297	235	4	300	1	271	2.012E-10	318
LOKIASV2_3079_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.184	297	224	16	312	7	282	1.033E-11	318
LOKIASV2_3079_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	0.143	293	224	16	308	6	267	3.963E-11	317
LOKIASV2_3079_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A TLK2 kinase domain from human	0.194	291	226	9	299	1	282	2.394E-11	317
LOKIASV2_3079_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.134	343	260	2	302	1	343	8.786E-13	317
LOKIASV2_3079_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.171	287	200	16	302	9	250	2.128E-10	316
LOKIASV2_3079_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	0.172	288	219	16	303	10	275	8.209E-11	316
LOKIASV2_3079_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.157	298	247	16	313	6	299	5.901E-12	316
LOKIASV2_3079_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.156	299	227	5	303	12	281	1.222E-11	316
LOKIASV2_3079_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.186	283	200	16	298	5	251	6.600E-12	315
LOKIASV2_3079_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A Structure of RIP2K(L294F) with bound AMPPCP	0.156	292	217	16	307	13	270	4.433E-11	315
LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.152	290	226	16	305	15	281	2.024E-11	315
LOKIASV2_3079_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	0.188	276	190	16	291	8	242	4.959E-11	314
LOKIASV2_3079_ESMFold_hypothetical_protein	5e8v-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5e8v-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A)	0.169	295	244	9	303	1	295	2.408E-12	314
LOKIASV2_3079_ESMFold_hypothetical_protein	3dgk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dgk-assembly1.cif.gz_A Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain	0.141	297	232	4	300	1	271	3.149E-10	313
LOKIASV2_3079_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B GSK-3 Beta complexed with AMP-PNP	0.176	291	229	14	304	20	298	1.809E-11	313
LOKIASV2_3079_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	0.166	288	197	16	303	6	242	1.437E-10	312
LOKIASV2_3079_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	0.125	297	232	4	300	1	266	3.725E-10	312
LOKIASV2_3079_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.183	287	196	16	302	11	251	4.192E-11	312
LOKIASV2_3079_ESMFold_hypothetical_protein	6kyr-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6kyr-assembly2.cif.gz_B Crystal structure of DCLK1 mutant (P675L) Autoinhibited Kinase Domain	0.186	292	211	16	307	11	270	2.394E-11	312
LOKIASV2_3079_ESMFold_hypothetical_protein	4o0w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4o0w-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.173	288	202	16	303	9	253	1.617E-11	311
LOKIASV2_3079_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	0.176	295	241	9	303	1	294	1.222E-11	311
LOKIASV2_3079_ESMFold_hypothetical_protein	4un0-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4un0-assembly1.cif.gz_C Crystal structure of the human CDK12-cyclinK complex	0.180	298	244	16	313	9	306	4.459E-12	311
LOKIASV2_3079_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	0.162	285	196	16	300	12	246	2.662E-10	310
LOKIASV2_3079_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A Aurora A Kinase in Complex with ATP in Space Group P6122	0.172	288	205	16	303	7	254	4.433E-11	310
LOKIASV2_3079_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	0.177	288	218	16	303	10	275	2.128E-10	310
LOKIASV2_3079_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	0.187	297	215	16	312	9	274	6.939E-11	310
LOKIASV2_3079_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.155	291	210	16	306	11	259	7.762E-11	310
LOKIASV2_3079_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.163	289	240	16	304	6	293	7.383E-12	310
LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.145	287	216	16	302	7	260	2.977E-10	309
LOKIASV2_3079_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)	0.203	296	208	16	311	4	265	7.762E-11	309
LOKIASV2_3079_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D Crystal structure of polo-like kinase 1	0.154	315	229	1	315	2	273	5.831E-10	309
LOKIASV2_3079_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	0.186	285	216	16	300	9	274	1.700E-10	309
LOKIASV2_3079_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	0.143	296	238	16	311	12	290	1.027E-10	309
LOKIASV2_3079_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.131	325	269	1	310	2	326	4.959E-11	309
LOKIASV2_3079_ESMFold_hypothetical_protein	4pte-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4pte-assembly1.cif.gz_B Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) to GSK3b	0.170	295	241	14	308	19	309	7.808E-12	309
LOKIASV2_3079_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.142	348	258	1	302	13	360	5.275E-12	309
LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.148	290	233	16	305	3	276	4.192E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.198	275	187	16	290	9	242	7.339E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.167	310	227	16	325	8	281	2.394E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH STAUROSPORINE	0.156	297	248	9	303	1	297	1.711E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	6kyq-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6kyq-assembly2.cif.gz_B Crystal structure of DCLK1 Autoinhibited Kinase Domain	0.180	292	212	16	307	11	269	3.747E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	LOKIASV2_3079_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.169	289	235	16	299	12	300	5.866E-11	308
LOKIASV2_3079_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	0.131	285	222	16	300	7	262	3.963E-11	307
LOKIASV2_3079_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B Structure of RIP2K(D146N) with bound Staurosporine	0.151	292	222	16	307	14	276	5.546E-11	307
LOKIASV2_3079_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	0.128	300	235	4	303	1	270	1.149E-10	307
LOKIASV2_3079_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.147	331	263	2	310	4	334	2.394E-11	307
LOKIASV2_3079_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin	0.162	296	211	20	315	20	272	2.012E-10	306
LOKIASV2_3079_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 902	0.153	297	223	3	299	1	264	1.608E-10	306
LOKIASV2_3079_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.153	289	241	16	304	6	291	2.394E-11	306
LOKIASV2_3079_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents	0.159	298	242	16	304	5	302	1.529E-11	306
LOKIASV2_3079_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A The crystal structure of the truncated form of Lotus japonicus kinase 1	0.158	285	237	14	298	30	311	2.263E-11	306
LOKIASV2_3079_ESMFold_hypothetical_protein	7kx6-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7kx6-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with XMD8-85	0.179	285	198	16	300	9	250	1.086E-10	305
LOKIASV2_3079_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.179	288	204	16	303	7	255	5.866E-11	305
LOKIASV2_3079_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	0.173	297	221	16	312	10	277	8.682E-11	305
LOKIASV2_3079_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.195	275	194	16	290	7	248	4.192E-11	305
LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.150	289	244	16	304	4	291	5.866E-11	305
LOKIASV2_3079_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.176	298	223	16	313	10	281	2.832E-11	304
LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.148	288	222	16	303	15	275	1.913E-11	304
LOKIASV2_3079_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.127	297	244	16	312	11	290	1.520E-10	304
LOKIASV2_3079_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	0.160	297	226	16	312	5	274	6.939E-11	304
LOKIASV2_3079_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.176	296	227	16	311	7	282	6.939E-11	304
LOKIASV2_3079_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.157	356	265	2	316	1	356	4.192E-11	304
LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.175	294	209	10	303	6	259	3.330E-10	303
LOKIASV2_3079_ESMFold_hypothetical_protein	4bn1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4bn1-assembly1.cif.gz_A Crystal structure of V174M mutant of Aurora-A kinase	0.178	288	207	16	303	8	260	6.939E-11	303
LOKIASV2_3079_ESMFold_hypothetical_protein	1h1w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1h1w-assembly1.cif.gz_A High resolution crystal structure of the human PDK1 catalytic domain	0.190	276	194	16	291	12	251	4.192E-11	303
LOKIASV2_3079_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	0.142	311	238	2	312	1	278	2.250E-10	303
LOKIASV2_3079_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C CDK2/CyclinA in complex with AZD5438	0.160	297	239	16	312	5	289	3.168E-11	303
LOKIASV2_3079_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.183	283	220	16	298	10	279	2.024E-11	303
LOKIASV2_3079_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.166	288	232	16	303	4	282	3.747E-11	303
LOKIASV2_3079_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.142	344	257	3	302	4	347	1.820E-12	303
LOKIASV2_3079_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.140	344	258	2	302	15	358	4.459E-12	303
LOKIASV2_3079_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.168	298	225	16	313	8	278	3.350E-11	302
LOKIASV2_3079_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.141	311	261	16	326	10	314	8.786E-13	302
LOKIASV2_3079_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.162	289	241	16	304	26	314	9.237E-12	302
LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.141	342	257	1	300	2	343	4.716E-12	302
LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.181	284	179	16	299	12	231	9.182E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F	LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.176	288	208	16	303	13	265	9.182E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	0.182	293	212	7	299	1	260	7.762E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	6qf4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6qf4-assembly1.cif.gz_A X-Ray structure of human Serine/Threonine Kinase 17B (STK17B) aka DRAK2 in complex with ADP obtained by on-chip soaking	0.163	296	216	20	315	20	278	9.712E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	5vlo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vlo-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.163	296	223	16	311	7	273	2.128E-10	301
LOKIASV2_3079_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	0.166	288	235	16	303	4	286	2.024E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	0.136	296	238	16	311	10	285	5.831E-10	301
LOKIASV2_3079_ESMFold_hypothetical_protein	8djc-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8djc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH (4S)-N-{4-[(2S)-2-methylmorpholin-4-yl] pyridin-3-yl}-2-phenylimidazo[1,2-b]pyridazine-8-carboxamide	0.183	291	221	14	304	20	290	4.192E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A GSK-3 Beta complexed with AMP-PNP	0.165	291	234	14	304	20	300	1.617E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	7pqs-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7pqs-assembly2.cif.gz_B SRPK1 in complex with MSC2711186	0.137	346	258	3	302	5	350	1.033E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.136	342	260	1	302	14	355	5.275E-12	301
LOKIASV2_3079_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.129	341	269	1	310	1	341	1.285E-10	301
LOKIASV2_3079_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	0.158	296	220	16	311	8	269	1.913E-11	301
LOKIASV2_3079_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	0.153	298	224	16	313	7	271	4.433E-11	300
LOKIASV2_3079_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	0.162	285	233	16	300	5	283	3.350E-11	300
LOKIASV2_3079_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.175	291	233	14	304	20	303	3.963E-11	300
LOKIASV2_3079_ESMFold_hypothetical_protein	4ueu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ueu-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl	0.191	287	196	16	302	11	253	2.128E-10	299
LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.150	291	232	16	306	2	275	6.204E-11	299
LOKIASV2_3079_ESMFold_hypothetical_protein	6gub-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6gub-assembly2.cif.gz_C CDK2/CyclinA in complex with Flavopiridol	0.162	297	237	16	312	5	288	1.809E-11	299
LOKIASV2_3079_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.154	288	241	16	303	5	290	1.149E-10	299
LOKIASV2_3079_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine	0.153	293	246	16	306	8	300	3.747E-11	299
LOKIASV2_3079_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	0.151	296	233	16	311	8	283	6.939E-11	299
LOKIASV2_3079_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	0.170	296	227	16	311	9	282	2.532E-11	299
LOKIASV2_3079_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	0.137	343	259	2	302	1	343	2.277E-12	299
LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.155	288	243	16	303	8	295	3.963E-11	298
LOKIASV2_3079_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.158	295	218	9	303	4	263	1.149E-10	298
LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.136	343	258	1	300	2	344	5.579E-12	298
LOKIASV2_3079_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	0.177	291	238	14	304	32	321	2.832E-11	298
LOKIASV2_3079_ESMFold_hypothetical_protein	2f2c-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2f2c-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanol	0.138	280	238	24	303	1	277	6.561E-11	297
LOKIASV2_3079_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.187	284	215	16	299	6	271	8.682E-11	296
LOKIASV2_3079_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR	0.159	302	224	15	316	14	280	1.080E-09	296
LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.152	288	241	16	303	6	290	5.244E-11	296
LOKIASV2_3079_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.159	295	218	9	303	2	261	1.520E-10	296
LOKIASV2_3079_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	0.173	288	196	16	303	7	244	7.762E-11	295
LOKIASV2_3079_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A Structure of ADP-bound human Nek7	0.173	291	200	16	306	14	256	2.977E-10	295
LOKIASV2_3079_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	0.128	310	242	4	313	1	279	4.929E-10	295
LOKIASV2_3079_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A Crystal structure of polo-like kinase 1	0.141	310	228	3	312	7	273	8.161E-10	295
LOKIASV2_3079_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A Crystal structure of a phosphorylated Polo-like kinase 1 (Plk1) catalytic domain in complex with ADP.	0.140	297	224	3	299	1	262	6.167E-10	295
LOKIASV2_3079_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.173	293	215	20	312	20	280	1.520E-10	295
LOKIASV2_3079_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	0.157	297	223	7	303	1	265	5.213E-10	294
LOKIASV2_3079_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.151	288	234	16	303	7	283	1.086E-10	294
LOKIASV2_3079_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.147	295	241	9	303	1	284	8.682E-11	294
LOKIASV2_3079_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.174	291	240	16	306	38	328	7.808E-12	294
LOKIASV2_3079_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_B Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	0.172	291	238	14	304	20	308	2.678E-11	294
LOKIASV2_3079_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.163	297	223	16	312	10	277	1.027E-10	293
LOKIASV2_3079_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	0.192	276	196	16	291	9	252	5.866E-11	293
LOKIASV2_3079_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b	0.157	288	234	16	303	7	285	1.520E-10	293
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.163	298	214	16	313	11	267	1.156E-11	293
LOKIASV2_3079_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine	0.163	291	243	16	306	34	324	4.433E-11	293
LOKIASV2_3079_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y with hematein	0.171	291	240	16	306	38	328	1.093E-11	293
LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.189	285	191	16	300	15	250	6.899E-10	292
LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.171	287	205	16	302	12	259	4.167E-10	292
LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.167	290	228	16	305	3	277	1.149E-10	292
LOKIASV2_3079_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	0.190	275	196	16	290	11	253	6.561E-11	292
LOKIASV2_3079_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.153	285	236	16	300	4	283	2.995E-11	292
LOKIASV2_3079_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.180	291	233	14	304	20	304	2.517E-10	292
LOKIASV2_3079_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A Crystal structure of apo DAPK1 in the presence of 18-crown-6	0.132	302	227	4	305	1	262	1.511E-09	291
LOKIASV2_3079_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	0.175	297	224	16	312	7	278	1.149E-10	291
LOKIASV2_3079_ESMFold_hypothetical_protein	3pwy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3pwy-assembly1.cif.gz_A Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2	0.202	275	187	16	290	12	246	1.700E-10	291
LOKIASV2_3079_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.166	289	240	16	304	31	319	1.093E-11	291
LOKIASV2_3079_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.180	284	206	16	299	7	258	1.359E-10	290
LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.167	297	221	16	312	7	272	8.209E-11	290
LOKIASV2_3079_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.177	293	240	16	308	52	344	1.617E-11	290
LOKIASV2_3079_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.173	302	217	7	308	1	263	1.446E-11	290
LOKIASV2_3079_ESMFold_hypothetical_protein	4aw1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4aw1-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket	0.184	276	193	16	291	14	251	9.712E-11	289
LOKIASV2_3079_ESMFold_hypothetical_protein	5s7t-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s7t-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a	0.148	288	234	16	303	7	282	1.086E-10	289
LOKIASV2_3079_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.171	291	239	16	306	33	321	1.293E-11	289
LOKIASV2_3079_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	0.167	295	225	16	310	8	278	1.215E-10	289
LOKIASV2_3079_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.130	343	259	2	300	1	343	8.209E-11	289
LOKIASV2_3079_ESMFold_hypothetical_protein	7uir-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7uir-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1 in complex with ATP	0.151	285	211	16	300	7	256	6.167E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	0.168	287	209	16	302	9	260	1.788E-09	288
LOKIASV2_3079_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	0.180	284	216	16	299	6	270	6.899E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Bosutinib isomer	0.165	280	201	16	295	43	284	3.522E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	0.128	300	234	16	315	9	277	3.940E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.165	291	240	16	306	33	321	2.678E-11	288
LOKIASV2_3079_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	0.140	321	256	1	299	7	327	5.514E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	5t31-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5t31-assembly1.cif.gz_A Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia	0.175	295	232	14	308	20	301	3.725E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.137	335	257	2	300	1	335	4.688E-11	288
LOKIASV2_3079_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_A Structural analysis of mouse GSK3beta fused with LRP6 peptide.	0.174	317	254	1	308	1	317	1.359E-10	288
LOKIASV2_3079_ESMFold_hypothetical_protein	7n3u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7n3u-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with ZN-c3	0.165	283	207	16	298	7	255	1.021E-09	287
LOKIASV2_3079_ESMFold_hypothetical_protein	7que-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7que-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CKJB68	0.138	285	216	16	300	12	262	1.798E-10	287
LOKIASV2_3079_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a	0.156	288	231	16	303	8	282	9.712E-11	287
LOKIASV2_3079_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	0.148	288	237	16	303	8	286	2.517E-10	287
LOKIASV2_3079_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A Kinase domain of ALK2-K493A with AMPPNP	0.152	286	242	16	301	3	288	3.522E-10	287
LOKIASV2_3079_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.174	298	214	9	306	2	261	2.250E-10	287
LOKIASV2_3079_ESMFold_hypothetical_protein	1q8y-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1q8y-assembly2.cif.gz_B The structure of the yeast SR protein kinase, Sky1p, with bound ADP	0.134	336	268	2	311	1	336	2.012E-10	287
LOKIASV2_3079_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib	0.165	280	201	16	295	34	275	5.213E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	0.150	288	215	16	303	22	275	1.690E-09	286
LOKIASV2_3079_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.160	298	229	9	306	2	275	4.407E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	4ptg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ptg-assembly1.cif.gz_A Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) to GSK3b	0.177	291	226	14	304	19	294	1.798E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.132	321	258	3	300	15	335	3.149E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	5f95-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5f95-assembly1.cif.gz_A Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylpyridin-3-yl)pyridine-4-carboxamide	0.172	291	237	14	304	19	305	1.520E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	6c9d-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6c9d-assembly1.cif.gz_A Crystal structure of KA1-autoinhibited MARK1 kinase	0.163	296	218	16	311	8	269	2.128E-10	286
LOKIASV2_3079_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	0.170	285	210	16	300	8	261	4.929E-10	285
LOKIASV2_3079_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	0.179	298	217	16	313	10	274	1.798E-10	285
LOKIASV2_3079_ESMFold_hypothetical_protein	3p1a-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3p1a-assembly1.cif.gz_A Structure of human Membrane-associated Tyrosine- and Threonine-specific cdc2-inhibitory kinase MYT1 (PKMYT1)	0.168	283	198	16	298	35	273	6.899E-10	285
LOKIASV2_3079_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	0.160	296	231	16	311	7	282	3.149E-10	285
LOKIASV2_3079_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	0.175	291	219	14	304	20	285	6.204E-11	285
LOKIASV2_3079_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	0.161	284	209	20	303	26	275	7.716E-10	284
LOKIASV2_3079_ESMFold_hypothetical_protein	5vd3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vd3-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (de-phosphorylated) IN COMPLEX WITH SARACATINIB	0.165	280	201	16	295	43	284	3.725E-10	284
LOKIASV2_3079_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	0.171	291	225	16	306	24	295	9.182E-11	284
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	0.174	316	233	16	331	9	291	2.394E-11	284
LOKIASV2_3079_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	0.163	291	243	16	306	38	328	5.244E-11	284
LOKIASV2_3079_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	0.169	288	197	16	303	3	240	1.902E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_D Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.143	285	201	16	300	7	241	1.142E-09	283
LOKIASV2_3079_ESMFold_hypothetical_protein	5ia3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ia3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with PD173955	0.187	291	198	16	306	12	255	3.940E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.164	280	199	16	295	30	268	4.661E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ATP/ADP at 111 MPa helium gas pressure in a sapphire capillary	0.161	283	216	20	302	20	277	3.149E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	0.149	291	245	16	304	10	300	6.204E-11	283
LOKIASV2_3079_ESMFold_hypothetical_protein	5f95-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5f95-assembly2.cif.gz_B Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylpyridin-3-yl)pyridine-4-carboxamide	0.186	291	225	14	304	19	296	1.608E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_A GSK-3 Beta complexed with Inhibitor I-5	0.178	291	229	14	304	20	299	1.149E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	0.185	291	229	14	304	20	301	1.149E-10	283
LOKIASV2_3079_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	0.132	348	260	3	302	7	354	1.222E-11	283
LOKIASV2_3079_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.182	288	200	16	303	8	252	1.285E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.184	293	201	16	308	15	261	9.128E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	7quf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7quf-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CK156	0.142	285	218	16	300	12	266	5.831E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE	0.158	293	244	16	306	9	301	6.939E-11	282
LOKIASV2_3079_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	0.178	298	200	16	313	9	252	8.209E-11	282
LOKIASV2_3079_ESMFold_hypothetical_protein	6z45-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6z45-assembly1.cif.gz_A CDK9-Cyclin-T1 complex bound by compound 24	0.153	300	251	16	315	15	311	1.520E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.166	309	256	3	310	4	312	1.608E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.149	323	258	9	331	2	305	2.012E-10	282
LOKIASV2_3079_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.159	290	241	16	305	33	320	2.532E-11	282
LOKIASV2_3079_ESMFold_hypothetical_protein	3m1s-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3m1s-assembly1.cif.gz_A Structure of Ruthenium Half-Sandwich Complex Bound to Glycogen Synthase Kinase 3	0.159	291	241	14	304	20	306	6.561E-11	282
LOKIASV2_3079_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C Aurora A in complex with a bisanilinopyrimidine	0.174	288	194	16	303	8	243	4.929E-10	281
LOKIASV2_3079_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	0.192	276	196	16	291	7	250	1.149E-10	281
LOKIASV2_3079_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.169	291	210	7	297	1	254	2.263E-11	281
LOKIASV2_3079_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.150	289	241	16	304	39	322	9.712E-11	280
LOKIASV2_3079_ESMFold_hypothetical_protein	7ncf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7ncf-assembly1.cif.gz_A Crystal structure of HIPK2 in complex with MU135 (compound 21e)	0.156	350	258	2	308	5	354	1.215E-10	280
LOKIASV2_3079_ESMFold_hypothetical_protein	3tub-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3tub-assembly1.cif.gz_A Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1R,2S)-2-phenylcyclopropyl)urea	0.165	287	198	20	306	14	251	2.128E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_B Crystal structure of unphosphorylated human PKR kinase domain in complex with ADP	0.171	289	198	16	304	13	252	7.716E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	0.188	291	201	16	306	9	256	1.351E-09	279
LOKIASV2_3079_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	0.173	297	218	16	312	8	272	2.250E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_B Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	0.165	288	213	16	303	19	274	2.815E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	5l2q-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5l2q-assembly1.cif.gz_A Serine/threonine-protein kinase 40 (STK40) kinase homology domain	0.159	292	236	16	307	10	291	8.161E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	0.158	295	247	10	304	1	294	2.128E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	1vjy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1vjy-assembly1.cif.gz_A Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor	0.163	295	244	18	312	7	299	1.027E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	5mah-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5mah-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.183	288	194	16	303	10	248	4.959E-11	279
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	0.188	297	204	16	312	10	261	5.546E-11	279
LOKIASV2_3079_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	0.176	284	232	16	299	37	318	7.339E-11	279
LOKIASV2_3079_ESMFold_hypothetical_protein	7a5n-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7a5n-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 34	0.141	320	256	1	299	5	324	7.716E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	1ias-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1ias-assembly1.cif.gz_A CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12	0.159	292	243	18	307	37	328	1.086E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A GSK-3 Beta complexed with Indirubin-3'-monoxime	0.172	291	229	14	304	20	296	1.520E-10	279
LOKIASV2_3079_ESMFold_hypothetical_protein	4i5m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4i5m-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	0.178	293	204	7	299	1	249	1.080E-09	278
LOKIASV2_3079_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	0.161	298	232	16	313	4	280	2.815E-10	278
LOKIASV2_3079_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	0.150	315	233	1	315	3	277	1.208E-09	278
LOKIASV2_3079_ESMFold_hypothetical_protein	5acb-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5acb-assembly2.cif.gz_D Crystal Structure of the Human Cdk12-Cyclink Complex	0.172	298	244	16	311	10	307	1.446E-11	278
LOKIASV2_3079_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	0.169	315	242	9	323	2	293	3.149E-10	278
LOKIASV2_3079_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor	0.183	291	228	14	304	21	300	2.250E-10	278
LOKIASV2_3079_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE	0.162	291	242	14	304	20	309	1.520E-10	278
LOKIASV2_3079_ESMFold_hypothetical_protein	7o2v-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7o2v-assembly1.cif.gz_A AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8	0.184	288	197	16	303	17	259	5.514E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly1.cif.gz_A Crystal structure of Nek7 SRS mutant bound to compound 51	0.182	291	206	16	306	14	266	5.831E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.192	275	191	16	290	7	243	2.128E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B)	0.151	296	215	20	315	20	273	2.815E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor NU-6140	0.166	284	216	16	299	4	263	3.522E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	5k4j-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5k4j-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with compound 22	0.163	284	218	16	299	5	266	6.167E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	0.150	288	235	16	303	8	285	9.128E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.162	300	216	20	319	18	276	8.682E-11	277
LOKIASV2_3079_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A Cdk2(F80C)	0.146	298	250	16	313	9	302	2.128E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	0.163	306	235	1	306	35	316	2.662E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	5nhp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5nhp-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.153	291	243	16	303	15	305	1.902E-10	277
LOKIASV2_3079_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	0.153	336	269	7	325	4	339	3.747E-11	277
LOKIASV2_3079_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	0.182	288	200	16	303	8	252	1.086E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.171	288	203	16	303	8	253	2.380E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	0.179	292	208	9	300	1	254	2.366E-09	276
LOKIASV2_3079_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ADP at atmospheric pressure	0.157	283	210	20	302	20	269	1.690E-09	276
LOKIASV2_3079_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	0.151	297	224	16	312	7	271	4.407E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	2j9m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2j9m-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with Macrocyclic Aminopyrimidine	0.172	288	216	16	303	4	265	2.128E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.192	275	188	16	290	9	242	3.725E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	0.152	298	226	16	313	6	273	1.027E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	0.169	284	232	16	299	37	316	4.192E-11	276
LOKIASV2_3079_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	0.170	290	240	16	305	36	325	9.182E-11	276
LOKIASV2_3079_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	0.141	323	256	1	299	6	328	4.167E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	0.176	288	232	16	303	38	319	2.263E-11	276
LOKIASV2_3079_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	0.181	302	215	7	308	1	263	1.608E-10	276
LOKIASV2_3079_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	0.170	288	202	16	303	8	251	2.380E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	5o26-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o26-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+	0.150	288	216	16	303	12	266	2.250E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.175	297	219	16	312	9	275	6.523E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.162	314	229	16	329	11	284	5.244E-11	275
LOKIASV2_3079_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A Crystal structure of Z. mays CK2 kinase alpha subunit in complex with the ATP-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole	0.174	293	241	16	308	33	325	2.012E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	0.136	324	257	2	299	14	337	2.128E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	0.146	303	254	7	304	6	308	3.168E-11	275
LOKIASV2_3079_ESMFold_hypothetical_protein	1h8f-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1h8f-assembly1.cif.gz_B Glycogen Synthase Kinase 3 beta.	0.168	291	240	14	304	20	309	1.215E-10	275
LOKIASV2_3079_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.177	288	201	16	303	6	250	5.514E-10	274
LOKIASV2_3079_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	0.179	289	236	16	304	33	321	4.688E-11	274
LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.143	346	256	1	300	2	347	2.832E-11	274
LOKIASV2_3079_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	0.161	288	217	16	303	522	781	6.167E-10	274
LOKIASV2_3079_ESMFold_hypothetical_protein	6sgd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6sgd-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24	0.186	283	186	16	298	6	235	3.149E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly2.cif.gz_B PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.195	275	193	16	290	6	246	7.339E-11	273
LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3orx-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.202	275	192	16	290	7	248	7.339E-11	273
LOKIASV2_3079_ESMFold_hypothetical_protein	6csw-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6csw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.159	309	256	2	310	1	305	4.929E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	0.170	314	240	9	322	2	291	5.213E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	6gn1-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6gn1-assembly2.cif.gz_A Crystal Structure of Glycogen synthase kinase-3 beta (GSK3B) in Complex with PIK-75	0.181	295	233	14	308	19	304	2.815E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	4nm0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4nm0-assembly1.cif.gz_A Crystal structure of peptide inhibitor-free GSK-3/Axin complex	0.167	291	241	14	304	26	315	1.215E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_B Structural analysis of mouse GSK3beta fused with LRP6 peptide.	0.175	291	237	14	304	33	320	1.902E-10	273
LOKIASV2_3079_ESMFold_hypothetical_protein	3dy7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dy7-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a complex with ligand and MgATP	0.151	288	214	16	303	7	259	4.407E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	4fkv-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4fkv-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.164	298	232	16	313	4	281	9.128E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.177	287	205	16	302	20	269	4.929E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.	0.157	288	240	16	303	5	290	3.522E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX	0.134	293	229	16	308	11	276	6.899E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	6xx9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6xx9-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form III	0.175	289	235	16	304	35	320	9.182E-11	272
LOKIASV2_3079_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	0.136	311	253	2	295	14	324	4.929E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	3juh-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3juh-assembly2.cif.gz_B Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificity	0.171	293	242	16	308	38	330	2.012E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	0.136	310	260	1	310	1	302	3.149E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	3zrm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3zrm-assembly1.cif.gz_A Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors	0.184	291	234	14	304	19	306	1.520E-10	272
LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.143	345	256	1	300	2	346	5.866E-11	272
LOKIASV2_3079_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_A Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.146	285	203	16	300	7	245	3.917E-09	271
LOKIASV2_3079_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.151	290	214	16	305	2	254	1.429E-09	271
LOKIASV2_3079_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	0.183	284	228	16	299	9	288	8.682E-11	271
LOKIASV2_3079_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.159	289	238	16	304	40	323	1.520E-10	271
LOKIASV2_3079_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.188	305	225	7	311	3	280	2.662E-10	271
LOKIASV2_3079_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	0.174	291	240	16	306	38	328	6.561E-11	271
LOKIASV2_3079_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-32	0.166	284	214	16	299	4	261	6.167E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	5s85-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s85-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c	0.160	301	234	3	303	1	280	2.517E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	0.167	284	207	20	303	27	276	1.080E-09	270
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.179	315	229	16	330	9	288	3.963E-11	270
LOKIASV2_3079_ESMFold_hypothetical_protein	3l1s-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3l1s-assembly1.cif.gz_A 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3	0.179	298	226	7	304	20	295	2.128E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	5hlp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5hlp-assembly1.cif.gz_A X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937	0.177	295	235	14	308	19	304	2.250E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	6b8j-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6b8j-assembly1.cif.gz_A Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine inhibitor	0.170	291	237	14	304	18	304	3.940E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_B Crystal structure of Rad53 1-466	0.189	283	193	16	298	135	373	3.940E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	4zhx-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4zhx-assembly2.cif.gz_C Novel binding site for allosteric activation of AMPK	0.180	302	215	7	308	1	263	2.517E-10	270
LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	0.170	291	203	16	306	12	256	2.799E-09	269
LOKIASV2_3079_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	0.159	297	223	16	312	4	269	6.523E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	0.166	285	220	16	300	2	266	7.296E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.193	276	191	16	291	11	248	2.662E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.158	298	236	16	313	4	284	8.161E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	LOKIASV2_3079_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.175	284	226	16	299	3	277	4.661E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit in D2O	0.173	288	232	16	303	37	318	7.339E-11	269
LOKIASV2_3079_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.162	305	237	7	311	2	285	2.977E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.141	319	254	2	298	14	332	1.021E-09	269
LOKIASV2_3079_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.166	300	247	16	315	15	311	3.747E-11	269
LOKIASV2_3079_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B GSK-3 Beta complexed with Indirubin-3'-monoxime	0.181	291	232	14	304	20	303	5.514E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	5kpm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5kpm-assembly1.cif.gz_A Glycogen Synthase Kinase 3 beta Complexed with BRD3731	0.167	295	242	14	308	19	309	3.522E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor	0.168	295	244	14	308	28	321	2.250E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	0.145	312	254	16	313	17	328	1.086E-10	269
LOKIASV2_3079_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.156	288	232	16	303	4	279	4.407E-10	268
LOKIASV2_3079_ESMFold_hypothetical_protein	3sqq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3sqq-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-3-96	0.172	284	222	16	299	4	272	5.514E-10	268
LOKIASV2_3079_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	0.151	304	233	3	306	4	278	6.858E-09	268
LOKIASV2_3079_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.183	296	198	16	311	11	253	1.215E-10	268
LOKIASV2_3079_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.165	299	220	7	305	1	264	1.902E-10	268
LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.185	291	203	16	306	15	264	1.690E-09	267
LOKIASV2_3079_ESMFold_hypothetical_protein	2ydi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2ydi-assembly1.cif.gz_A Discovery of Checkpoint Kinase Inhibitor AZD7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas	0.174	284	208	16	299	8	260	7.716E-10	267
LOKIASV2_3079_ESMFold_hypothetical_protein	8bok-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8bok-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 11	0.210	291	203	16	306	9	266	6.523E-10	267
LOKIASV2_3079_ESMFold_hypothetical_protein	6hxf-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6hxf-assembly3.cif.gz_C Human STK10 bound to a maleimide inhibitor	0.159	295	230	12	306	10	284	8.631E-10	267
LOKIASV2_3079_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.155	288	214	16	303	23	276	3.917E-09	267
LOKIASV2_3079_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.168	289	240	16	304	33	321	9.712E-11	267
LOKIASV2_3079_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	0.179	287	190	16	302	9	240	3.130E-09	266
LOKIASV2_3079_ESMFold_hypothetical_protein	5vd9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vd9-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-097, a MK1775 analogue	0.172	284	205	16	299	8	255	8.580E-09	266
LOKIASV2_3079_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	0.183	297	216	16	312	8	272	4.167E-10	266
LOKIASV2_3079_ESMFold_hypothetical_protein	3lfn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3lfn-assembly1.cif.gz_A Crystal structure of CDK2 with SAR57, an aminoindazole type inhibitor	0.154	297	233	16	312	4	279	1.700E-10	266
LOKIASV2_3079_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A MELK in complex with NVS-MELK8A	0.172	300	212	16	315	10	266	8.682E-11	266
LOKIASV2_3079_ESMFold_hypothetical_protein	5kpl-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5kpl-assembly2.cif.gz_B Glycogen Synthase Kinase 3 beta Complexed with BRD0705	0.172	291	233	14	304	19	300	3.149E-10	266
LOKIASV2_3079_ESMFold_hypothetical_protein	4j1r-assembly6.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4j1r-assembly6.cif.gz_C Crystal Structure of GSK3b in complex with inhibitor 15R	0.176	291	235	14	304	19	304	4.661E-10	266
LOKIASV2_3079_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.177	288	198	16	303	7	247	5.831E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	5vda-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vda-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue	0.174	286	207	16	301	7	257	1.502E-08	265
LOKIASV2_3079_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	0.225	291	200	16	306	13	271	2.977E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.165	302	246	2	303	1	296	6.523E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A Human vaccinia-related kinase 1	0.156	303	253	3	303	3	305	2.815E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	0.171	291	240	16	306	38	328	1.215E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B Crystal Structure of PF11_0147	0.147	300	246	16	304	12	311	2.250E-10	265
LOKIASV2_3079_ESMFold_hypothetical_protein	6c9f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6c9f-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	0.177	307	223	7	313	1	272	5.244E-11	265
LOKIASV2_3079_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	0.184	288	195	16	303	7	246	3.522E-10	264
LOKIASV2_3079_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	0.152	284	221	16	299	4	265	9.654E-10	264
LOKIASV2_3079_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_A Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	0.171	284	230	16	299	1	279	8.161E-10	264
LOKIASV2_3079_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B A novel small molecule aPKC inhibitor	0.180	287	209	16	302	7	262	2.380E-10	264
LOKIASV2_3079_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	0.137	324	255	3	299	1	324	4.633E-09	264
LOKIASV2_3079_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.150	283	202	16	298	15	253	6.523E-10	263
LOKIASV2_3079_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	0.158	288	232	16	303	7	282	3.940E-10	263
LOKIASV2_3079_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D CDK1/CyclinB1/CKS2 in complex with NU6102	0.147	284	232	16	299	7	279	2.000E-09	263
LOKIASV2_3079_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	0.145	284	234	16	299	7	281	2.517E-10	263
LOKIASV2_3079_ESMFold_hypothetical_protein	5o7i-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o7i-assembly1.cif.gz_A ERK5 in complex with a pyrrole inhibitor	0.142	290	244	16	300	2	291	2.250E-10	263
LOKIASV2_3079_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.179	288	194	16	303	7	243	1.891E-09	262
LOKIASV2_3079_ESMFold_hypothetical_protein	8ej4-assembly1.cif.gz_K	LOKIASV2_3079_ESMFold_hypothetical_protein	8ej4-assembly1.cif.gz_K Cryo-EM structure of the active NLRP3 inflammasome disk	0.173	290	203	16	305	15	260	3.703E-09	262
LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly3.cif.gz_C Crystal structure of Nek7 bound to compound 51	0.179	291	203	16	306	13	260	2.000E-09	262
LOKIASV2_3079_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	0.158	284	221	16	299	4	266	1.429E-09	262
LOKIASV2_3079_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	0.154	298	235	16	313	4	282	9.128E-10	262
LOKIASV2_3079_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	0.157	298	240	16	313	9	294	5.831E-10	262
LOKIASV2_3079_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	0.173	295	204	16	310	6	253	1.608E-10	262
LOKIASV2_3079_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.164	296	209	16	311	7	257	2.250E-10	262
LOKIASV2_3079_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	0.117	308	264	6	305	2	309	3.725E-10	262
LOKIASV2_3079_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	0.186	288	190	16	303	8	241	1.690E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.173	288	202	16	303	7	251	2.115E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.191	291	201	16	306	15	264	2.366E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.169	283	224	16	298	3	273	6.523E-10	261
LOKIASV2_3079_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A Structure of Alk5 + GW855857	0.155	289	241	18	306	7	292	5.831E-10	261
LOKIASV2_3079_ESMFold_hypothetical_protein	4imy-assembly3.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	4imy-assembly3.cif.gz_E The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat	0.164	304	252	16	319	12	313	4.929E-10	261
LOKIASV2_3079_ESMFold_hypothetical_protein	5tvt-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5tvt-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	0.171	303	211	16	318	12	267	2.977E-10	261
LOKIASV2_3079_ESMFold_hypothetical_protein	5ukf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ukf-assembly1.cif.gz_A Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.171	304	249	3	303	4	307	2.662E-10	261
LOKIASV2_3079_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	0.151	291	228	16	306	7	275	1.142E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	6ccy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6ccy-assembly1.cif.gz_A Crystal structure of Akt1 in complex with a selective inhibitor	0.173	315	241	9	323	5	296	1.021E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	0.129	324	259	2	299	1	324	2.366E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D Crystal structure of GSK3beta complexed with Morin	0.174	291	228	14	304	19	295	1.429E-09	261
LOKIASV2_3079_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.171	288	195	16	303	10	245	9.128E-10	260
LOKIASV2_3079_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	0.167	288	200	16	303	7	247	1.021E-09	260
LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A Crystal structure of Nek7 bound to compound 51	0.192	291	200	16	306	16	264	6.131E-09	260
LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly2.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly2.cif.gz_H Crystal structure of the BRAF:MEK1 complex	0.140	295	224	16	310	3	264	3.703E-09	260
LOKIASV2_3079_ESMFold_hypothetical_protein	5kz7-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5kz7-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.166	296	201	16	311	6	247	5.213E-10	260
LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_A Structure of MELK in complex with inhibitors	0.173	297	198	16	312	12	252	4.407E-10	260
LOKIASV2_3079_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	0.162	291	241	16	306	37	324	1.608E-10	260
LOKIASV2_3079_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	0.168	283	213	16	298	9	265	8.161E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	5vio-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5vio-assembly4.cif.gz_D Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)	0.162	283	214	20	302	15	270	1.788E-09	259
LOKIASV2_3079_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A Cdk2(WT) with covalent adduct at C177	0.145	297	247	16	312	3	292	6.899E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.174	296	202	16	311	6	251	3.725E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	4bl1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4bl1-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with AMP-PNP	0.177	296	198	16	311	10	250	3.725E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	0.156	317	242	9	325	2	289	1.080E-09	259
LOKIASV2_3079_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A Structure of PKC in Complex with a Substrate Peptide from Par-3	0.178	296	224	16	311	6	279	6.523E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	0.171	291	240	16	306	38	328	1.700E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.149	287	217	16	302	21	276	3.940E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2 Crystal structure and mechanism of activation of TBK1	0.125	307	261	7	305	1	307	6.899E-10	259
LOKIASV2_3079_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.184	288	199	16	303	7	251	7.296E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	0.195	291	201	16	306	15	265	2.646E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	5bvw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5bvw-assembly1.cif.gz_A Fragment-based discovery of potent and selective DDR1/2 inhibitors	0.126	291	232	16	306	7	273	6.484E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	4fkw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4fkw-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.168	285	217	16	300	4	265	1.142E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	0.143	326	248	3	328	1	290	7.716E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	3rpv-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3rpv-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-88	0.152	298	245	16	313	4	293	3.330E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	0.160	289	202	16	304	12	253	3.940E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	6dd4-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6dd4-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.166	308	256	3	310	3	310	1.208E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	5lih-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5lih-assembly2.cif.gz_B Structure of a peptide-substrate bound to PKCiota core kinase domain	0.174	288	207	16	303	6	256	1.429E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	0.153	291	246	16	306	37	327	1.608E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A Human Protein Kinase N2 (PKN2, PRKCL2) in complex with ATPgammaS	0.148	305	240	2	306	1	283	1.511E-09	258
LOKIASV2_3079_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.173	301	247	16	315	15	315	1.359E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	0.153	298	233	16	313	39	314	5.213E-10	258
LOKIASV2_3079_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B Crystal structure of Aurora-A in complex with a pentacyclic inhibitor	0.168	288	198	16	303	6	244	1.142E-09	257
LOKIASV2_3079_ESMFold_hypothetical_protein	6sgi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6sgi-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 96	0.202	285	188	16	300	6	241	1.690E-09	257
LOKIASV2_3079_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	0.202	283	201	16	298	6	258	9.654E-10	257
LOKIASV2_3079_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated state with chloride bound in the active site	0.142	283	218	16	298	12	266	3.130E-09	257
LOKIASV2_3079_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A Crystal structure of a CDK inhibitor bound to CDK2	0.150	297	235	16	312	4	280	1.080E-09	257
LOKIASV2_3079_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.	0.152	295	227	16	310	8	276	5.831E-10	257
LOKIASV2_3079_ESMFold_hypothetical_protein	7b7r-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7b7r-assembly2.cif.gz_B MEK1 in complex with compound 4	0.149	295	218	16	310	30	286	1.429E-09	257
LOKIASV2_3079_ESMFold_hypothetical_protein	5m5a-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5m5a-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.171	298	204	16	313	10	256	4.929E-10	257
LOKIASV2_3079_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.168	327	240	1	327	3	292	1.359E-10	257
LOKIASV2_3079_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 562	0.139	311	216	3	313	1	252	1.343E-08	256
LOKIASV2_3079_ESMFold_hypothetical_protein	7khj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7khj-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state	0.153	306	215	1	306	6	260	2.366E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration	0.162	285	206	16	300	8	254	4.900E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	6s76-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s76-assembly1.cif.gz_A Crystal structure of human Nek7	0.196	291	200	16	306	14	263	2.960E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.183	291	210	16	306	8	265	6.484E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D Crystal Structure of Domain-Swapped OSR1 kinase domain	0.166	288	226	16	303	11	282	4.929E-10	256
LOKIASV2_3079_ESMFold_hypothetical_protein	3r8m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3r8m-assembly1.cif.gz_A CDK2 in complex with inhibitor L3-3	0.153	284	225	16	299	4	270	6.167E-10	256
LOKIASV2_3079_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	0.169	288	225	16	303	5	276	6.131E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	3r8z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3r8z-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-136	0.166	298	238	16	313	4	289	1.788E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A MEK1 in complex with compound 6	0.153	291	211	16	306	36	285	1.598E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	0.154	302	251	2	303	1	298	1.891E-09	256
LOKIASV2_3079_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.152	298	236	16	313	30	308	2.380E-10	256
LOKIASV2_3079_ESMFold_hypothetical_protein	5byy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5byy-assembly1.cif.gz_A ERK5 IN COMPLEX WITH SMALL MOLECULE	0.138	288	247	16	303	7	293	2.662E-10	256
LOKIASV2_3079_ESMFold_hypothetical_protein	5xzv-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5xzv-assembly2.cif.gz_B Crystal structure of Rad53 1-466 in complex with AMP-PNP	0.183	285	194	16	300	130	367	7.296E-10	256
LOKIASV2_3079_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	0.174	288	197	16	303	7	246	1.351E-09	255
LOKIASV2_3079_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	0.191	285	195	16	300	6	247	1.021E-09	255
LOKIASV2_3079_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.163	288	216	16	303	6	264	1.511E-09	255
LOKIASV2_3079_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B Structure of a MAPK pathway complex	0.146	295	224	16	310	13	275	1.429E-09	255
LOKIASV2_3079_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.145	309	227	11	319	14	279	6.523E-10	255
LOKIASV2_3079_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.171	296	206	16	311	3	251	4.929E-10	255
LOKIASV2_3079_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	0.185	313	237	16	328	6	297	9.128E-10	255
LOKIASV2_3079_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	0.181	288	210	16	303	7	263	3.149E-10	255
LOKIASV2_3079_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	0.170	288	232	16	303	37	316	1.359E-10	255
LOKIASV2_3079_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A Crystal structure of WNK3 kinase and CCT1 didomain in a unphosphorylated state	0.133	280	217	20	299	23	273	2.000E-09	255
LOKIASV2_3079_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.153	285	194	16	300	8	237	8.580E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with wortmannin.	0.143	301	225	3	303	1	263	8.580E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A ALK-5 kinase complex with GW857175	0.157	289	234	18	306	7	284	1.429E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	0.169	284	221	16	299	4	270	2.502E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	0.155	295	225	16	310	8	274	1.788E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	0.142	288	238	16	303	13	290	4.929E-10	254
LOKIASV2_3079_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	0.159	288	217	16	303	162	420	2.000E-09	254
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.156	283	202	16	298	7	246	2.000E-09	253
LOKIASV2_3079_ESMFold_hypothetical_protein	4uzd-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4uzd-assembly2.cif.gz_B SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.179	288	201	16	303	9	254	6.167E-10	253
LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	0.162	280	202	19	298	13	254	6.131E-09	253
LOKIASV2_3079_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	0.171	288	208	16	303	11	262	1.135E-08	253
LOKIASV2_3079_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	0.175	288	208	16	303	8	260	1.429E-09	253
LOKIASV2_3079_ESMFold_hypothetical_protein	3qc4-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3qc4-assembly2.cif.gz_B PDK1 in complex with DFG-OUT inhibitor xxx	0.188	288	201	16	303	17	264	5.213E-10	253
LOKIASV2_3079_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148N mutant	0.173	288	232	16	303	37	318	1.902E-10	253
LOKIASV2_3079_ESMFold_hypothetical_protein	6fnf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6fnf-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with NVP-BHG712	0.199	291	193	16	306	8	249	5.213E-10	252
LOKIASV2_3079_ESMFold_hypothetical_protein	3q53-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3q53-assembly1.cif.gz_A Structure of phosphorylated PAK1 kinase domain in complex with ATP	0.177	287	207	16	302	21	273	3.703E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	3qti-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3qti-assembly1.cif.gz_A c-Met Kinase in Complex with NVP-BVU972	0.145	299	221	20	318	31	290	1.511E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	7b94-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7b94-assembly2.cif.gz_B MEK1 in complex with compound 6	0.149	295	216	16	310	28	282	1.788E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A MEK1 in complex with compound 6	0.156	295	213	16	310	36	288	3.502E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	0.144	297	246	2	298	14	301	8.113E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.154	301	253	3	303	3	302	1.080E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 2	0.136	325	256	3	299	1	325	4.142E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	7z5n-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7z5n-assembly2.cif.gz_B Crystal structure of DYRK1A in complex with CX-4945	0.131	325	256	4	299	14	338	6.131E-09	252
LOKIASV2_3079_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.149	287	217	16	302	21	276	5.213E-10	252
LOKIASV2_3079_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	0.176	288	194	16	303	8	243	6.131E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.175	283	203	16	298	5	251	1.598E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	2xzs-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2xzs-assembly2.cif.gz_B Death associated protein kinase 1 residues 1-312	0.136	296	235	16	311	10	282	2.000E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor	0.157	308	252	3	310	1	300	4.900E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	0.164	296	218	16	311	7	268	1.437E-10	251
LOKIASV2_3079_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	0.160	288	234	16	303	37	315	2.977E-10	251
LOKIASV2_3079_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.151	300	236	16	315	30	308	2.662E-10	251
LOKIASV2_3079_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.145	313	254	2	299	13	325	8.113E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	7jou-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	7jou-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.148	288	228	16	303	68	336	2.799E-09	251
LOKIASV2_3079_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.152	280	195	20	299	14	244	2.224E-08	250
LOKIASV2_3079_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.186	288	190	16	303	9	243	1.788E-09	250
LOKIASV2_3079_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	0.130	312	218	4	315	1	251	1.135E-08	250
LOKIASV2_3079_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_C Crystal structure of the kinase domain of CIPK24/SOS2	0.166	289	210	16	304	5	257	2.799E-09	250
LOKIASV2_3079_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.168	296	206	16	311	6	253	2.815E-10	250
LOKIASV2_3079_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.163	300	244	4	303	1	292	2.115E-09	250
LOKIASV2_3079_ESMFold_hypothetical_protein	4euu-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4euu-assembly1.cif.gz_B Structure of BX-795 Complexed with Human TBK1 Kinase Domain Phosphorylated on Ser172	0.120	307	262	7	305	1	307	9.128E-10	250
LOKIASV2_3079_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	0.175	283	224	16	298	36	308	3.149E-10	250
LOKIASV2_3079_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.172	304	227	7	310	2	276	5.213E-10	250
LOKIASV2_3079_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	0.149	299	235	16	314	44	320	7.296E-10	250
LOKIASV2_3079_ESMFold_hypothetical_protein	3zhp-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3zhp-assembly1.cif.gz_D Human MST3 (STK24) in complex with MO25beta	0.186	283	195	16	298	5	244	6.131E-09	249
LOKIASV2_3079_ESMFold_hypothetical_protein	2w5a-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2w5a-assembly1.cif.gz_A Human Nek2 kinase ADP-bound	0.199	285	200	16	300	6	256	9.654E-10	249
LOKIASV2_3079_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	0.142	304	231	3	306	5	274	2.366E-09	249
LOKIASV2_3079_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	0.159	284	236	16	299	38	319	4.661E-10	249
LOKIASV2_3079_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A Crystal structure of a rhoptry kinase from toxoplasma gondii	0.134	302	254	5	306	48	341	1.788E-09	249
LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	0.163	279	197	20	298	14	249	3.917E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.135	285	212	16	300	11	256	1.074E-08	248
LOKIASV2_3079_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	0.157	284	207	16	299	5	251	6.131E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.140	285	219	16	300	5	260	3.481E-08	248
LOKIASV2_3079_ESMFold_hypothetical_protein	8boc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8boc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 19	0.196	291	201	16	306	9	259	3.311E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP	0.179	288	204	16	303	25	273	7.716E-10	248
LOKIASV2_3079_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A Human CDK2 with type II inhibitor	0.168	285	222	16	300	4	271	1.690E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.182	287	204	16	302	24	273	9.654E-10	248
LOKIASV2_3079_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B Structure of the N-terminal domain of SAD	0.156	289	203	16	304	12	252	1.021E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995	0.150	325	269	2	319	1	325	1.700E-10	248
LOKIASV2_3079_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.172	300	240	16	315	61	351	1.142E-09	248
LOKIASV2_3079_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	0.141	285	198	16	300	3	233	1.074E-08	247
LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_D Crystal structure of the BRAF:MEK1 complex	0.150	295	229	16	310	3	272	4.900E-09	247
LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	0.188	310	225	16	325	4	281	1.142E-09	247
LOKIASV2_3079_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to JA-296	0.148	301	251	3	303	1	296	4.633E-09	247
LOKIASV2_3079_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C Crystal structure of the protein kinase CK2 catalytic domain from Plasmodium falciparum bound to ATP	0.173	298	237	16	313	32	318	5.866E-11	247
LOKIASV2_3079_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	0.176	288	229	16	303	38	316	4.661E-10	247
LOKIASV2_3079_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	0.152	299	234	16	314	43	319	8.161E-10	247
LOKIASV2_3079_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	0.151	299	234	16	314	43	319	4.929E-10	247
LOKIASV2_3079_ESMFold_hypothetical_protein	2vd5-assembly2.cif.gz_B-3	LOKIASV2_3079_ESMFold_hypothetical_protein	2vd5-assembly2.cif.gz_B-3 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.183	298	226	16	313	61	338	7.716E-10	247
LOKIASV2_3079_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_A Crystal structure of STING CTD in complex with TBK1	0.132	308	260	6	305	5	312	3.502E-09	247
LOKIASV2_3079_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B Structure of Aurora-2 in complex with PHA-739358	0.166	288	200	16	303	6	246	4.381E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	3o50-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3o50-assembly2.cif.gz_B Crystal structure of benzamide 9 bound to AuroraA	0.163	288	198	16	303	8	245	8.580E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.140	283	211	16	298	15	260	5.183E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	4fg8-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4fg8-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-315 in complex with ATP	0.170	298	203	16	313	7	252	6.858E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	5we8-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5we8-assembly2.cif.gz_B Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)	0.141	284	217	16	299	14	267	6.858E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	0.146	295	230	16	310	8	277	3.703E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	0.191	291	210	16	306	8	267	1.080E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	0.149	300	236	16	315	26	303	1.021E-09	246
LOKIASV2_3079_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	0.159	299	207	16	314	9	255	3.130E-09	245
LOKIASV2_3079_ESMFold_hypothetical_protein	2c3l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2c3l-assembly1.cif.gz_A Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification	0.160	288	208	16	303	8	256	8.580E-09	245
LOKIASV2_3079_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	0.167	283	229	16	298	37	312	3.522E-10	245
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.133	288	234	16	303	68	338	4.900E-09	245
LOKIASV2_3079_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118	0.142	295	228	16	310	9	275	1.080E-09	245
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.163	284	198	16	299	8	244	1.429E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	0.148	285	208	16	300	5	249	2.352E-08	244
LOKIASV2_3079_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.158	284	215	16	299	11	266	3.130E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR	0.160	297	224	16	312	4	271	6.131E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	3dv3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dv3-assembly1.cif.gz_A MEK1 with PF-04622664 Bound	0.156	295	225	16	310	8	275	3.130E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B MEK1 in complex with compound 23	0.161	295	215	16	310	28	284	4.381E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	7z9t-assembly1.cif.gz_AAA	LOKIASV2_3079_ESMFold_hypothetical_protein	7z9t-assembly1.cif.gz_AAA Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, Y35 out), P 1 21 1	0.144	304	255	5	303	3	306	6.523E-10	244
LOKIASV2_3079_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.141	308	259	5	306	43	350	2.237E-09	244
LOKIASV2_3079_ESMFold_hypothetical_protein	4anb-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4anb-assembly1.cif.gz_A Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.	0.150	295	220	16	310	11	270	1.988E-08	243
LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	0.182	304	223	16	319	10	283	1.891E-09	243
LOKIASV2_3079_ESMFold_hypothetical_protein	3fy0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3fy0-assembly1.cif.gz_A Crystal structure of PAK1 kinase domain with ruthenium complex DW1	0.173	287	206	16	302	25	274	1.208E-09	243
LOKIASV2_3079_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	0.144	299	236	16	314	46	322	4.661E-10	243
LOKIASV2_3079_ESMFold_hypothetical_protein	5jn2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5jn2-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to NVPACU106	0.143	295	228	16	310	9	275	2.000E-09	243
LOKIASV2_3079_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	0.149	291	228	16	306	196	464	2.366E-09	243
LOKIASV2_3079_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolution	0.176	283	193	16	298	7	241	6.131E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.170	283	196	16	298	8	244	1.880E-08	242
LOKIASV2_3079_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A Crystal structure of human WEE2 kinase domain in complex with MK1775	0.172	283	204	16	298	9	255	2.960E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.162	281	204	20	300	14	257	1.135E-08	242
LOKIASV2_3079_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	0.175	284	208	16	299	7	259	7.253E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.155	292	228	16	307	10	280	2.000E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	0.161	295	222	16	310	14	279	2.960E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	0.149	312	226	16	327	7	272	1.598E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	0.158	299	232	16	314	30	306	1.788E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	4rgj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4rgj-assembly1.cif.gz_A Apo crystal structure of CDPK4 from Plasmodium falciparum, PF3D7_0717500	0.157	305	226	3	307	10	278	1.511E-09	242
LOKIASV2_3079_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.146	288	208	20	307	15	258	3.291E-08	241
LOKIASV2_3079_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_C Crystal structure of human calmodulin-dependent protein kinase 1D	0.153	297	202	16	312	13	251	5.797E-09	241
LOKIASV2_3079_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.150	304	246	1	304	5	294	1.788E-09	241
LOKIASV2_3079_ESMFold_hypothetical_protein	3f88-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3f88-assembly2.cif.gz_B glycogen synthase Kinase 3beta inhibitor complex	0.169	311	255	14	324	20	327	2.237E-09	241
LOKIASV2_3079_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.127	332	261	1	300	6	337	2.977E-10	241
LOKIASV2_3079_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	0.157	320	264	7	320	5	324	3.940E-10	241
LOKIASV2_3079_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	0.144	332	251	16	309	40	371	1.608E-10	241
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.174	284	198	16	299	8	248	1.135E-08	240
LOKIASV2_3079_ESMFold_hypothetical_protein	7up6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7up6-assembly1.cif.gz_A Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal)	0.136	308	207	20	327	15	255	4.606E-08	240
LOKIASV2_3079_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	0.198	288	189	16	303	11	247	1.502E-08	240
LOKIASV2_3079_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	0.160	298	207	9	306	2	249	1.680E-08	240
LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3vvh-assembly3.cif.gz_C X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	0.159	295	221	16	310	8	271	8.580E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	0.160	288	224	16	303	12	279	1.690E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_A Crystal structure of the BRAF:MEK1 complex	0.156	295	228	16	310	6	276	1.135E-08	240
LOKIASV2_3079_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	LOKIASV2_3079_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	0.162	298	230	16	313	29	304	3.917E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E Crystal structure of R336A mutant of cAMP-dependent protein kinase with unphosphorylated turn motif.	0.147	298	235	16	313	30	305	1.598E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA	0.146	298	235	16	313	31	306	2.000E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	0.147	298	235	16	313	34	309	2.000E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	0.138	296	231	16	311	72	340	4.633E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	5w80-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5w80-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237	0.141	296	229	16	311	8	275	4.633E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.148	298	228	16	313	6	274	1.788E-09	240
LOKIASV2_3079_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.167	288	191	16	303	8	237	1.015E-08	239
LOKIASV2_3079_ESMFold_hypothetical_protein	6sgk-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6sgk-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 102	0.191	298	195	16	313	6	247	2.799E-09	239
LOKIASV2_3079_ESMFold_hypothetical_protein	8otz-assembly1.cif.gz_x	LOKIASV2_3079_ESMFold_hypothetical_protein	8otz-assembly1.cif.gz_x 48-nm repeat of the native axonemal doublet microtubule from bovine sperm	0.190	283	203	16	298	2	252	6.484E-09	239
LOKIASV2_3079_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.133	294	230	9	302	1	266	4.871E-08	239
LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23 T190D mutant	0.186	288	209	16	303	13	270	1.511E-09	239
LOKIASV2_3079_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	0.150	319	252	9	327	114	411	1.598E-09	239
LOKIASV2_3079_ESMFold_hypothetical_protein	5jms-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5jms-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to CGP060476	0.146	295	227	16	310	8	274	3.311E-09	239
LOKIASV2_3079_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	0.174	282	194	16	297	7	242	9.654E-10	238
LOKIASV2_3079_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	0.148	306	250	5	310	3	297	1.598E-09	238
LOKIASV2_3079_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	0.154	299	233	16	314	30	306	3.311E-09	238
LOKIASV2_3079_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	0.157	298	232	16	313	31	306	9.654E-10	238
LOKIASV2_3079_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	0.141	298	236	16	313	46	321	1.891E-09	238
LOKIASV2_3079_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.175	282	203	20	301	15	261	6.484E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B Crystal Structure of Domain-Swapped OSR1 kinase domain	0.152	288	224	16	303	12	276	1.074E-08	237
LOKIASV2_3079_ESMFold_hypothetical_protein	7p1l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7p1l-assembly1.cif.gz_A The MARK3 Kinase Domain Bound To AA-CS-1-008	0.142	312	228	16	327	7	273	1.021E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.162	296	211	16	311	7	259	2.250E-10	237
LOKIASV2_3079_ESMFold_hypothetical_protein	7xnc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7xnc-assembly1.cif.gz_A MEK1 bound to DS94070624	0.157	295	224	16	310	32	298	4.633E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	0.153	298	233	16	313	35	310	1.511E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	0.145	288	214	16	303	33	283	7.671E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.181	291	198	16	306	132	374	2.115E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.137	288	227	16	303	70	333	1.135E-08	237
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.130	288	236	16	303	70	341	1.502E-08	237
LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.139	296	231	16	311	73	341	1.880E-08	237
LOKIASV2_3079_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.126	288	239	16	303	70	344	5.183E-09	237
LOKIASV2_3079_ESMFold_hypothetical_protein	5wdy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5wdy-assembly1.cif.gz_A Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.152	287	209	16	302	13	259	4.633E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	4x7l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4x7l-assembly1.cif.gz_A Co-crystal Structure of PERK bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor	0.181	297	201	16	312	9	255	7.253E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	5tf9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5tf9-assembly1.cif.gz_A Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.153	287	210	16	302	11	259	1.015E-08	236
LOKIASV2_3079_ESMFold_hypothetical_protein	4j8m-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4j8m-assembly1.cif.gz_A Aurora A in complex with CD532	0.165	288	210	16	303	9	260	2.502E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ326	0.167	288	216	16	303	12	271	2.366E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D Human STK10 bound to a maleimide inhibitor	0.163	291	225	16	306	14	283	4.381E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 8 (CS275)	0.160	298	224	16	313	12	279	2.799E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	4ark-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ark-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP	0.155	295	228	16	310	8	278	7.671E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B Crystal structure of SPAK (STK39) dimer in the basal activity state	0.174	288	222	16	303	11	280	1.021E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	2cmw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2cmw-assembly1.cif.gz_A Structure of Human Casein kinase 1 gamma-1 in complex with 2-(2- Hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine	0.178	290	221	17	306	2	271	1.502E-08	236
LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	0.181	313	225	2	314	1	276	2.799E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	0.172	296	205	16	311	6	254	1.208E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	0.155	295	218	9	303	2	260	6.484E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	5lih-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5lih-assembly1.cif.gz_A Structure of a peptide-substrate bound to PKCiota core kinase domain	0.168	296	223	16	311	7	275	1.511E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	0.162	314	261	7	320	5	316	4.167E-10	236
LOKIASV2_3079_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A Protein kinase A catalytic subunit in complex with PKI5-24 and EN068	0.142	299	237	16	314	46	322	9.128E-10	236
LOKIASV2_3079_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.134	311	261	5	306	43	353	3.130E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.142	282	212	16	297	70	317	2.487E-08	236
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.136	288	234	16	303	70	341	9.075E-09	236
LOKIASV2_3079_ESMFold_hypothetical_protein	5oq6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5oq6-assembly1.cif.gz_A Structure of CHK1 12-pt. mutant complex with aminopyrimido-benzodiazepinone LRRK2 inhibitor	0.149	285	208	16	300	5	249	2.487E-08	235
LOKIASV2_3079_ESMFold_hypothetical_protein	4x7n-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4x7n-assembly1.cif.gz_A Co-crystal Structure of PERK bound to 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor	0.177	299	203	16	314	9	256	2.103E-08	235
LOKIASV2_3079_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2 Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ331	0.167	298	200	16	313	12	252	3.894E-08	235
LOKIASV2_3079_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.182	287	197	16	302	17	258	6.858E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	0.169	288	223	16	303	11	279	1.690E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.160	296	206	16	311	6	251	1.788E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23	0.181	305	222	1	305	1	272	2.237E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	3zm4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3zm4-assembly1.cif.gz_A Crystal structure of MEK1 in complex with fragment 1	0.158	295	225	16	310	29	296	4.900E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.154	296	217	16	311	13	269	1.208E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	0.146	298	235	16	313	36	311	2.799E-09	235
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.132	295	237	16	310	68	341	1.015E-08	235
LOKIASV2_3079_ESMFold_hypothetical_protein	5we8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5we8-assembly1.cif.gz_A Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)	0.136	287	220	16	302	12	267	6.131E-09	234
LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23 T190D mutant	0.189	299	214	16	314	5	269	5.481E-09	234
LOKIASV2_3079_ESMFold_hypothetical_protein	5fqd-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5fqd-assembly1.cif.gz_C Structural basis of Lenalidomide induced CK1a degradation by the crl4crbn ubiquitin ligase	0.146	301	238	9	309	2	281	1.074E-08	234
LOKIASV2_3079_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	0.147	299	235	16	314	43	319	1.277E-09	234
LOKIASV2_3079_ESMFold_hypothetical_protein	4wot-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4wot-assembly1.cif.gz_C ROCK2 IN COMPLEX WITH 1426382-07-1	0.135	288	237	16	303	71	345	1.201E-08	234
LOKIASV2_3079_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	0.152	298	233	16	313	98	373	2.366E-09	234
LOKIASV2_3079_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.145	296	237	16	311	162	439	2.487E-08	234
LOKIASV2_3079_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A Crystal structure of PLK4 kinase	0.147	285	185	16	300	13	230	2.942E-08	233
LOKIASV2_3079_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.172	288	190	16	303	8	238	1.777E-08	233
LOKIASV2_3079_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.192	287	192	16	302	20	258	4.381E-09	233
LOKIASV2_3079_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.162	301	243	3	303	1	291	1.270E-08	233
LOKIASV2_3079_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	0.163	288	198	16	303	10	247	1.208E-09	233
LOKIASV2_3079_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	0.149	299	234	16	314	31	306	1.429E-09	233
LOKIASV2_3079_ESMFold_hypothetical_protein	3v51-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3v51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor RM-1-176	0.139	296	229	16	311	9	275	1.074E-08	233
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.170	283	198	16	298	8	247	2.103E-08	232
LOKIASV2_3079_ESMFold_hypothetical_protein	3sls-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3sls-assembly1.cif.gz_A Crystal Structure of human MEK-1 kinase in complex with UCB1353770 and AMPPNP	0.154	295	212	16	310	27	278	1.343E-08	232
LOKIASV2_3079_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	0.176	291	222	16	306	7	277	1.343E-08	232
LOKIASV2_3079_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A MEK1 in complex with compound 23	0.140	295	215	16	310	36	286	1.015E-08	232
LOKIASV2_3079_ESMFold_hypothetical_protein	8efj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8efj-assembly1.cif.gz_A A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds	0.154	314	264	7	320	5	317	1.598E-09	232
LOKIASV2_3079_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.139	296	233	16	311	72	343	1.988E-08	232
LOKIASV2_3079_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	0.171	299	203	16	314	9	254	1.421E-08	231
LOKIASV2_3079_ESMFold_hypothetical_protein	1zxe-assembly3.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	1zxe-assembly3.cif.gz_E Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.161	291	211	16	306	8	260	3.894E-08	231
LOKIASV2_3079_ESMFold_hypothetical_protein	4fg9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4fg9-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.159	298	198	16	313	11	247	6.131E-09	231
LOKIASV2_3079_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D	0.162	301	204	16	316	13	256	3.703E-09	231
LOKIASV2_3079_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP	0.157	295	228	16	310	8	278	1.270E-08	231
LOKIASV2_3079_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.147	298	236	9	306	2	279	1.589E-08	231
LOKIASV2_3079_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.166	288	199	16	303	6	245	1.429E-09	231
LOKIASV2_3079_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	0.142	298	236	16	313	35	310	2.237E-09	231
LOKIASV2_3079_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.136	295	236	16	310	71	344	4.118E-08	231
LOKIASV2_3079_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	0.149	291	234	16	306	149	424	6.484E-09	231
LOKIASV2_3079_ESMFold_hypothetical_protein	3dae-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dae-assembly1.cif.gz_A Crystal structure of phosphorylated SNF1 kinase domain	0.166	290	196	16	305	8	243	5.797E-09	230
LOKIASV2_3079_ESMFold_hypothetical_protein	2xno-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2xno-assembly1.cif.gz_A Structure of Nek2 bound to CCT243779	0.194	285	189	16	300	6	240	1.201E-08	230
LOKIASV2_3079_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.167	283	198	16	298	8	246	9.021E-08	230
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.171	311	240	16	326	7	297	1.080E-09	230
LOKIASV2_3079_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_A Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.156	314	261	7	320	6	315	7.296E-10	230
LOKIASV2_3079_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	0.148	292	244	15	306	58	344	3.502E-09	230
LOKIASV2_3079_ESMFold_hypothetical_protein	4iwq-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4iwq-assembly1.cif.gz_A Crystal structure and mechanism of activation of TBK1	0.130	296	244	10	305	5	286	4.633E-09	230
LOKIASV2_3079_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_C TRK-A IN COMPLEX WITH LIGAND	0.170	291	215	16	306	11	270	1.777E-08	229
LOKIASV2_3079_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C Crystal structure of CDK4/cyclin D3	0.157	285	238	16	298	2	286	9.597E-09	229
LOKIASV2_3079_ESMFold_hypothetical_protein	8gds-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8gds-assembly2.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.128	288	234	16	303	69	337	1.589E-08	229
LOKIASV2_3079_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	0.137	288	230	16	303	68	334	2.224E-08	229
LOKIASV2_3079_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_C PKR kinase domain- eIF2alpha- AMP-PNP complex.	0.149	288	161	16	303	11	200	1.671E-07	228
LOKIASV2_3079_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	0.172	284	206	16	299	4	253	6.095E-08	228
LOKIASV2_3079_ESMFold_hypothetical_protein	4zjj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4zjj-assembly1.cif.gz_A PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide	0.184	283	193	20	302	26	263	6.484E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.161	304	225	16	319	10	278	5.183E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.153	287	233	14	300	2	277	1.080E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A BRAF-MEK complex with AMP-PCP bound to BRAF	0.157	295	227	16	310	26	295	1.343E-08	228
LOKIASV2_3079_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	0.152	298	233	16	313	34	309	3.311E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A Fragment N13460a in complex with MAP kinase p38-alpha	0.152	322	270	2	320	1	322	9.654E-10	228
LOKIASV2_3079_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3	LOKIASV2_3079_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.123	288	238	16	303	66	337	1.201E-08	228
LOKIASV2_3079_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	0.140	296	238	16	311	72	349	2.631E-08	228
LOKIASV2_3079_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	0.163	300	218	7	306	109	370	4.381E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	3ku2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ku2-assembly1.cif.gz_A Crystal Structure of inactivated form of CDPK1 from toxoplasma gondii, TGME49.101440	0.142	298	230	16	313	8	276	6.858E-09	228
LOKIASV2_3079_ESMFold_hypothetical_protein	5sau-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5sau-assembly1.cif.gz_A DDR1, 3-[2-(6-aminopyridin-3-yl)ethynyl]-N-[3-(trifluoromethyl)phenyl]benzamide, 1.800A, P212121, Rfree=23.1%	0.133	288	238	16	303	7	282	3.112E-08	227
LOKIASV2_3079_ESMFold_hypothetical_protein	3sls-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3sls-assembly2.cif.gz_B Crystal Structure of human MEK-1 kinase in complex with UCB1353770 and AMPPNP	0.156	295	214	16	310	27	280	2.782E-08	227
LOKIASV2_3079_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A Rsk2 C-terminal Kinase Domain, (E)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate	0.174	297	221	16	312	15	283	1.777E-08	227
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.171	295	209	16	310	6	258	3.703E-09	227
LOKIASV2_3079_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	0.158	288	233	16	303	36	313	1.021E-09	227
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.136	288	233	16	303	70	340	1.777E-08	227
LOKIASV2_3079_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	0.165	292	215	16	307	7	265	4.381E-09	227
LOKIASV2_3079_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B Crystal structure of PLK4 kinase	0.145	285	186	16	300	13	230	1.009E-07	226
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.153	298	204	16	313	8	249	1.502E-08	226
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.166	283	202	16	298	7	249	1.343E-08	226
LOKIASV2_3079_ESMFold_hypothetical_protein	8xfl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8xfl-assembly1.cif.gz_A The Crystal Structure of MARK4 from Biortus.	0.177	325	219	2	326	1	267	2.115E-09	226
LOKIASV2_3079_ESMFold_hypothetical_protein	3eqd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3eqd-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with ATP-GS and MG2P	0.142	295	233	16	310	30	302	1.343E-08	226
LOKIASV2_3079_ESMFold_hypothetical_protein	2onl-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2onl-assembly2.cif.gz_B Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.159	314	261	7	320	6	316	1.277E-09	226
LOKIASV2_3079_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.204	291	204	16	306	132	388	5.481E-09	226
LOKIASV2_3079_ESMFold_hypothetical_protein	2wqe-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2wqe-assembly1.cif.gz_A Structure of S155R Aurora-A somatic mutant	0.156	288	195	16	303	7	238	3.502E-09	225
LOKIASV2_3079_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA	LOKIASV2_3079_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)	0.157	288	218	16	303	12	271	9.075E-09	225
LOKIASV2_3079_ESMFold_hypothetical_protein	5dey-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5dey-assembly2.cif.gz_B Crystal structure of PAK1 in complex with an inhibitor compound G-5555	0.169	287	204	16	302	16	261	2.487E-08	225
LOKIASV2_3079_ESMFold_hypothetical_protein	4lmn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4lmn-assembly1.cif.gz_A Crystal Structure of MEK1 kinase bound to GDC0973	0.166	288	224	16	303	8	276	7.671E-09	225
LOKIASV2_3079_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.143	294	243	2	295	1	284	8.631E-10	225
LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.130	296	241	16	311	63	340	2.782E-08	225
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.167	283	188	16	298	7	233	5.763E-08	224
LOKIASV2_3079_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	0.127	313	245	16	328	10	291	2.352E-08	224
LOKIASV2_3079_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.150	284	225	16	299	4	269	1.021E-09	224
LOKIASV2_3079_ESMFold_hypothetical_protein	1jbp-assembly1.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	1jbp-assembly1.cif.gz_E Crystal Structure of the Catalytic Subunit of cAMP-dependent Protein Kinase Complexed with a Substrate Peptide, ADP and Detergent	0.144	298	235	16	313	35	310	1.270E-08	224
LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.135	298	220	16	313	73	327	2.942E-08	224
LOKIASV2_3079_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.137	296	239	16	311	72	349	8.065E-08	224
LOKIASV2_3079_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.135	279	202	20	298	15	249	1.671E-07	223
LOKIASV2_3079_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.130	281	190	20	300	16	234	6.095E-08	223
LOKIASV2_3079_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK24/SOS2	0.162	289	210	16	304	5	255	1.777E-08	223
LOKIASV2_3079_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	0.140	313	256	1	313	7	305	1.277E-09	223
LOKIASV2_3079_ESMFold_hypothetical_protein	5r92-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5r92-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP kinase p38-alpha	0.162	322	266	2	320	1	322	9.654E-10	223
LOKIASV2_3079_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.141	296	230	16	311	73	341	2.782E-08	223
LOKIASV2_3079_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A Crystal structure of anthranilamide 10 bound to AuroraA	0.155	288	199	16	303	8	243	8.580E-09	222
LOKIASV2_3079_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA	LOKIASV2_3079_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)	0.146	288	219	16	303	12	268	1.988E-08	222
LOKIASV2_3079_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A In cellulo Crystal Structure of PAK4 in complex with Inka	0.167	288	211	16	303	48	301	1.129E-07	222
LOKIASV2_3079_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	0.130	311	258	8	304	13	323	4.900E-09	222
LOKIASV2_3079_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_B Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	0.121	300	262	7	305	1	300	5.797E-09	222
LOKIASV2_3079_ESMFold_hypothetical_protein	3os3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3os3-assembly1.cif.gz_A Mitogen-activated protein kinase kinase 1 (MEK1) in complex with CH4858061 and MgATP	0.170	287	207	16	302	7	256	1.067E-07	221
LOKIASV2_3079_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.155	298	204	16	313	7	248	5.449E-08	221
LOKIASV2_3079_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.176	283	199	20	302	26	267	1.201E-08	221
LOKIASV2_3079_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	0.135	296	236	9	304	2	275	2.782E-08	221
LOKIASV2_3079_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.141	297	234	8	304	3	275	1.074E-08	221
LOKIASV2_3079_ESMFold_hypothetical_protein	5wnf-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5wnf-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.144	296	229	16	311	73	341	2.103E-08	221
LOKIASV2_3079_ESMFold_hypothetical_protein	3t3u-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3t3u-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with Bumped Kinase Inhibitor, RM-1-130	0.151	298	228	16	313	7	275	9.597E-09	221
LOKIASV2_3079_ESMFold_hypothetical_protein	2jam-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2jam-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase I G	0.144	293	230	16	308	6	275	3.917E-09	220
LOKIASV2_3079_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.155	310	259	7	316	5	311	2.502E-09	220
LOKIASV2_3079_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTION	0.157	314	261	5	315	3	316	3.917E-09	220
LOKIASV2_3079_ESMFold_hypothetical_protein	3fkl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3fkl-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO9552	0.158	316	264	7	320	6	321	3.703E-09	220
LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F	LOKIASV2_3079_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.168	283	198	16	298	7	245	5.449E-08	219
LOKIASV2_3079_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	0.135	298	238	16	313	30	305	6.131E-09	219
LOKIASV2_3079_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.143	297	230	8	304	3	271	3.681E-08	219
LOKIASV2_3079_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_A ROCK 1 bound to a pyridine thiazole inhibitor	0.133	296	238	16	311	71	346	7.210E-08	219
LOKIASV2_3079_ESMFold_hypothetical_protein	8wf4-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8wf4-assembly2.cif.gz_B The Crystal Structure of RSK1 from Biortus.	0.163	298	222	16	313	4	269	7.210E-08	218
LOKIASV2_3079_ESMFold_hypothetical_protein	4ixp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4ixp-assembly1.cif.gz_A Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK)	0.169	297	217	16	312	10	271	8.113E-09	218
LOKIASV2_3079_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A Crystal structure of Human CAMK4 in complex with 4-Amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)	0.162	302	218	3	304	1	261	5.152E-08	217
LOKIASV2_3079_ESMFold_hypothetical_protein	5okt-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5okt-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.129	291	226	16	306	6	266	1.015E-08	217
LOKIASV2_3079_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A Crystal structure of SPAK (STK39) dimer in the basal activity state	0.169	291	229	16	306	11	287	1.135E-08	217
LOKIASV2_3079_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	0.136	291	234	16	306	7	278	8.530E-08	217
LOKIASV2_3079_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	0.142	285	195	16	300	10	237	8.530E-08	216
LOKIASV2_3079_ESMFold_hypothetical_protein	4zjj-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4zjj-assembly2.cif.gz_B PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide	0.169	287	199	16	302	20	260	2.782E-08	216
LOKIASV2_3079_ESMFold_hypothetical_protein	4nt4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4nt4-assembly1.cif.gz_A Crystal structure of the kinase domain of Gilgamesh isoform I from Drosophila melanogaster	0.159	291	231	16	306	9	284	1.680E-08	216
LOKIASV2_3079_ESMFold_hypothetical_protein	5cvg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5cvg-assembly1.cif.gz_A Crystal Structure of CK2alpha with a novel closed conformation of the aD loop	0.159	288	236	16	303	36	317	2.960E-09	216
LOKIASV2_3079_ESMFold_hypothetical_protein	5t6i-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5t6i-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TGCDPK1 FROM TOXOPLASMA GONDII COMPLEXED WITH 5GB	0.116	295	232	16	310	8	270	1.777E-08	216
LOKIASV2_3079_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804	0.135	298	249	16	313	4	292	4.633E-09	215
LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23 T190D mutant	0.182	313	226	2	314	1	277	1.074E-08	215
LOKIASV2_3079_ESMFold_hypothetical_protein	1r39-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1r39-assembly1.cif.gz_A THE STRUCTURE OF P38ALPHA	0.143	318	268	7	320	6	323	9.654E-10	215
LOKIASV2_3079_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.140	296	238	16	311	72	349	1.009E-07	215
LOKIASV2_3079_ESMFold_hypothetical_protein	3n51-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3n51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.145	298	229	16	313	7	275	1.343E-08	215
LOKIASV2_3079_ESMFold_hypothetical_protein	6n3o-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6n3o-assembly1.cif.gz_A Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	0.162	298	205	16	313	7	252	2.782E-08	214
LOKIASV2_3079_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3	0.157	291	225	16	306	3	270	9.541E-08	214
LOKIASV2_3079_ESMFold_hypothetical_protein	4tw9-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4tw9-assembly1.cif.gz_B Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation	0.143	300	232	7	306	1	272	5.152E-08	214
LOKIASV2_3079_ESMFold_hypothetical_protein	7m0z-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7m0z-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and CH5126766	0.150	297	230	16	312	27	298	3.112E-08	214
LOKIASV2_3079_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9h	0.149	313	259	7	319	5	309	5.183E-09	214
LOKIASV2_3079_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	0.144	314	265	7	320	5	315	6.858E-09	214
LOKIASV2_3079_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	0.115	305	264	7	305	1	305	1.270E-08	214
LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A Crystal Structure of Domain-Swapped OSR1 kinase domain	0.147	288	226	16	303	12	277	1.421E-08	213
LOKIASV2_3079_ESMFold_hypothetical_protein	7n91-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7n91-assembly1.cif.gz_A P70 S6K1 IN COMPLEX WITH MSC2317067A-1	0.175	291	209	16	306	7	260	5.152E-08	213
LOKIASV2_3079_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain	0.155	293	234	14	306	57	334	4.118E-08	213
LOKIASV2_3079_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A Crystal structure of MAPK13 at INACTIVE FORM	0.143	297	250	7	303	9	301	1.080E-09	213
LOKIASV2_3079_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	0.142	285	189	16	300	9	229	2.338E-07	212
LOKIASV2_3079_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.158	295	214	12	306	18	272	1.589E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.140	298	223	16	313	4	263	2.942E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	0.162	287	210	16	302	16	267	3.894E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	0.147	313	260	7	319	5	310	6.131E-09	212
LOKIASV2_3079_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A Crystal structure of p38delta kinase	0.142	294	246	7	300	11	298	3.130E-09	212
LOKIASV2_3079_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	0.147	299	248	15	306	58	356	2.782E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.151	269	183	16	284	68	284	5.152E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.135	288	226	16	303	70	331	1.412E-07	212
LOKIASV2_3079_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.138	288	232	16	303	68	337	2.338E-07	212
LOKIASV2_3079_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	0.148	302	239	9	310	157	438	3.481E-08	212
LOKIASV2_3079_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL166	0.151	297	245	7	303	5	293	6.858E-09	211
LOKIASV2_3079_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	0.134	294	252	7	300	5	296	1.343E-08	211
LOKIASV2_3079_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	0.154	287	218	16	302	8	266	1.502E-08	211
LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_A Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.164	295	212	16	310	30	284	2.782E-08	210
LOKIASV2_3079_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A HUMAN P38 MAP KINASE INHIBITOR COMPLEX	0.144	297	241	7	303	5	286	6.484E-09	210
LOKIASV2_3079_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	0.144	299	233	16	314	28	300	1.270E-08	210
LOKIASV2_3079_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	0.153	289	237	7	295	5	285	3.311E-09	210
LOKIASV2_3079_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	0.148	293	246	14	306	57	346	3.112E-08	210
LOKIASV2_3079_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	0.151	296	230	16	311	7	278	1.589E-08	210
LOKIASV2_3079_ESMFold_hypothetical_protein	5hze-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5hze-assembly1.cif.gz_A Mek1 adopts DFG-out conformation when bound to an analog of E6201.	0.132	292	228	16	307	26	289	6.446E-08	209
LOKIASV2_3079_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor	0.144	299	248	5	303	4	294	9.075E-09	209
LOKIASV2_3079_ESMFold_hypothetical_protein	6y80-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6y80-assembly1.cif.gz_A Fragment KCL_916 in complex with MAP kinase p38-alpha	0.161	297	246	7	303	5	298	3.502E-09	209
LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly3.cif.gz_E	LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.132	288	233	16	303	70	339	9.541E-08	209
LOKIASV2_3079_ESMFold_hypothetical_protein	5kks-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5kks-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole inhibitor	0.136	296	239	16	311	72	349	4.606E-08	209
LOKIASV2_3079_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.143	298	213	9	306	1	250	3.681E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	5w4w-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	5w4w-assembly3.cif.gz_C Identification and Profiling of a Selective and Brain Penetrant Radioligand for In Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors	0.135	291	227	16	306	6	269	7.210E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.146	296	225	16	311	10	273	3.291E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449	0.140	305	252	5	309	3	296	6.484E-09	208
LOKIASV2_3079_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.141	296	218	16	311	72	326	8.530E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.153	288	209	16	303	72	319	4.871E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632	0.119	282	226	16	297	68	324	1.671E-07	208
LOKIASV2_3079_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	0.142	319	239	9	327	108	386	2.487E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.132	298	228	16	313	71	334	8.530E-08	208
LOKIASV2_3079_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	0.134	287	229	17	303	9	274	3.681E-08	207
LOKIASV2_3079_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_D Heterodimeric structure of ERK2 and RSK1	0.156	298	227	16	313	6	275	1.671E-07	207
LOKIASV2_3079_ESMFold_hypothetical_protein	3o8p-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3o8p-assembly1.cif.gz_A Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding	0.134	313	267	7	319	5	313	6.484E-09	207
LOKIASV2_3079_ESMFold_hypothetical_protein	4kin-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4kin-assembly2.cif.gz_B Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE	0.158	297	247	7	303	6	299	1.680E-08	207
LOKIASV2_3079_ESMFold_hypothetical_protein	4h36-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4h36-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with ATF2 Peptide	0.143	329	265	7	316	5	333	9.075E-09	207
LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.138	269	203	16	284	70	306	1.335E-07	207
LOKIASV2_3079_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.144	291	222	16	306	3	262	1.777E-08	206
LOKIASV2_3079_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.145	308	206	20	327	16	257	7.626E-08	206
LOKIASV2_3079_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C crystal structure of ck1d with PF670462 from P1 crystal form	0.152	298	230	16	313	6	277	5.152E-08	206
LOKIASV2_3079_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib	0.145	300	209	7	306	3	248	1.335E-07	206
LOKIASV2_3079_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	0.149	298	248	7	304	4	295	4.606E-08	206
LOKIASV2_3079_ESMFold_hypothetical_protein	5o90-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o90-assembly1.cif.gz_A Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide.	0.168	316	252	5	320	3	306	5.797E-09	206
LOKIASV2_3079_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.133	288	238	16	303	66	340	1.869E-07	206
LOKIASV2_3079_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated apo state (A-loop swapped)	0.139	283	214	16	298	13	261	9.541E-08	205
LOKIASV2_3079_ESMFold_hypothetical_protein	6ru7-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6ru7-assembly2.cif.gz_B Crystal structure of Casein Kinase I delta (CK1d) in complex with double phosphorylated p63 PAD2P peptide	0.146	304	231	3	306	1	272	1.976E-07	205
LOKIASV2_3079_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	0.148	297	233	16	312	31	305	1.343E-08	205
LOKIASV2_3079_ESMFold_hypothetical_protein	4iwp-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4iwp-assembly1.cif.gz_A Crystal structure and mechanism of activation of TBK1	0.111	299	252	7	305	2	286	6.446E-08	205
LOKIASV2_3079_ESMFold_hypothetical_protein	6pxp-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6pxp-assembly3.cif.gz_A Human Casein Kinase 1 delta Site 2 mutant (K171E)	0.135	305	235	2	306	1	273	2.090E-07	204
LOKIASV2_3079_ESMFold_hypothetical_protein	5hvu-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5hvu-assembly1.cif.gz_B Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor	0.120	296	240	16	311	72	345	1.767E-07	204
LOKIASV2_3079_ESMFold_hypothetical_protein	4kba-assembly5.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4kba-assembly5.cif.gz_A CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor	0.137	298	213	9	306	1	248	2.766E-07	203
LOKIASV2_3079_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	0.136	300	237	7	306	1	275	1.335E-07	203
LOKIASV2_3079_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_A Heterodimeric structure of ERK2 and RSK1	0.161	300	227	16	315	6	277	1.009E-07	203
LOKIASV2_3079_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 33	0.135	314	270	7	320	5	317	1.421E-08	203
LOKIASV2_3079_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with AMP-PNP	0.173	288	207	16	303	28	278	6.817E-08	202
LOKIASV2_3079_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.125	291	229	16	306	8	270	1.067E-07	202
LOKIASV2_3079_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	0.168	297	243	7	303	4	296	1.680E-08	202
LOKIASV2_3079_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	0.126	285	219	16	300	13	264	1.976E-07	201
LOKIASV2_3079_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	0.129	291	229	16	306	6	269	1.129E-07	201
LOKIASV2_3079_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_D CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.162	287	204	16	302	22	265	3.681E-08	200
LOKIASV2_3079_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	0.152	314	252	16	313	7	320	2.631E-08	200
LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.156	291	224	16	306	12	277	7.210E-08	200
LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.138	288	213	16	303	68	315	1.580E-07	200
LOKIASV2_3079_ESMFold_hypothetical_protein	7nh5-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7nh5-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 6	0.149	298	212	9	306	108	357	1.767E-07	200
LOKIASV2_3079_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.153	288	198	16	303	5	239	2.338E-07	199
LOKIASV2_3079_ESMFold_hypothetical_protein	7up7-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7up7-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.142	310	209	20	329	15	259	2.090E-07	199
LOKIASV2_3079_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.130	298	233	9	306	1	269	1.580E-07	199
LOKIASV2_3079_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.148	297	248	7	303	9	300	1.589E-08	199
LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.163	288	212	16	303	18	271	1.009E-07	199
LOKIASV2_3079_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	0.133	298	208	9	306	93	333	1.671E-07	199
LOKIASV2_3079_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3	0.147	319	235	9	327	108	383	7.210E-08	199
LOKIASV2_3079_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.148	288	201	16	303	3	239	2.615E-07	198
LOKIASV2_3079_ESMFold_hypothetical_protein	7szc-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7szc-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	0.189	172	119	16	187	19	166	2.078E-06	197
LOKIASV2_3079_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.148	279	199	20	298	21	255	1.869E-07	197
LOKIASV2_3079_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	0.139	313	233	16	328	71	342	1.009E-07	197
LOKIASV2_3079_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	0.195	168	122	20	187	20	172	1.485E-06	196
LOKIASV2_3079_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.151	288	203	16	303	3	242	2.925E-07	196
LOKIASV2_3079_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31	0.146	298	200	9	306	110	344	1.494E-07	196
LOKIASV2_3079_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.183	275	196	16	290	6	246	2.942E-08	196
LOKIASV2_3079_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 18	0.143	296	225	16	311	12	275	6.446E-08	195
LOKIASV2_3079_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	0.159	299	235	16	314	5	284	4.871E-08	195
LOKIASV2_3079_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	0.154	298	237	16	313	78	358	9.021E-08	195
LOKIASV2_3079_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.175	288	205	16	303	26	275	2.352E-08	194
LOKIASV2_3079_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.144	296	222	16	311	13	272	2.615E-07	193
LOKIASV2_3079_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	0.158	299	247	5	303	3	296	3.894E-08	193
LOKIASV2_3079_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_A Crystal structure of Rad53 1-466	0.185	283	186	16	298	146	374	4.579E-07	193
LOKIASV2_3079_ESMFold_hypothetical_protein	7jhh-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7jhh-assembly1.cif.gz_A Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody	0.183	275	196	16	290	6	246	1.580E-07	193
LOKIASV2_3079_ESMFold_hypothetical_protein	4yur-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4yur-assembly1.cif.gz_A Crystal Structure of Plk4 Kinase Domain Bound to Centrinone	0.132	285	186	16	300	8	222	6.408E-07	192
LOKIASV2_3079_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	0.143	296	225	16	311	12	275	3.660E-07	192
LOKIASV2_3079_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.138	296	227	16	311	11	274	7.626E-08	191
LOKIASV2_3079_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A p38alpha MAP kinase bound to MPAQ	0.155	290	234	7	296	5	282	5.449E-08	191
LOKIASV2_3079_ESMFold_hypothetical_protein	5yj9-assembly1.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5yj9-assembly1.cif.gz_D Crystal structure of Tribolium castaneum PINK1 kinase domain in complex with AMP-PNP	0.150	285	225	20	304	1	266	1.009E-07	191
LOKIASV2_3079_ESMFold_hypothetical_protein	6cje-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6cje-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in complex with Inhibitor	0.126	288	225	16	303	13	271	3.094E-07	190
LOKIASV2_3079_ESMFold_hypothetical_protein	3bv3-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3bv3-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2	0.149	296	245	5	300	3	291	1.335E-07	190
LOKIASV2_3079_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5B, a pseudokinase GDI	0.138	292	247	15	306	59	346	2.211E-07	190
LOKIASV2_3079_ESMFold_hypothetical_protein	5xs2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5xs2-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH COMPOUND 17:3-chloro-4-(4-pyridyl)-1H-pyrrole-2-carboxamide	0.131	317	250	16	304	23	339	3.460E-07	190
LOKIASV2_3079_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	0.134	310	215	1	310	8	256	2.338E-07	189
LOKIASV2_3079_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	0.183	311	225	1	311	1	277	1.255E-06	189
LOKIASV2_3079_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.146	291	225	16	306	6	270	4.871E-08	189
LOKIASV2_3079_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2 CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor	0.144	291	229	16	306	7	274	4.843E-07	189
LOKIASV2_3079_ESMFold_hypothetical_protein	8x88-assembly3.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8x88-assembly3.cif.gz_A The Crystal Structure of TNIK from Biortus.	0.136	292	242	16	307	11	291	1.767E-07	189
LOKIASV2_3079_ESMFold_hypothetical_protein	3nnx-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3nnx-assembly1.cif.gz_A Crystal structure of phosphorylated P38 alpha in complex with DP802	0.158	313	259	7	319	5	313	6.817E-08	189
LOKIASV2_3079_ESMFold_hypothetical_protein	4im0-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4im0-assembly1.cif.gz_A-2 Structure of Tank-Binding Kinase 1	0.126	300	246	6	305	1	282	7.210E-08	189
LOKIASV2_3079_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	0.151	295	227	16	310	8	275	7.168E-07	188
LOKIASV2_3079_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B Crystal structure of the human CDK7 kinase domain in complex with LDC4297	0.151	283	216	16	298	4	258	3.871E-07	187
LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.132	298	199	16	313	72	301	5.152E-08	187
LOKIASV2_3079_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	0.153	296	220	16	311	10	270	2.766E-07	186
LOKIASV2_3079_ESMFold_hypothetical_protein	4i5h-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4i5h-assembly1.cif.gz_A Crystal Structure of a Double Mutant Rat Erk2 Complexed With a Type II Quinazoline Inhibitor	0.153	288	240	16	303	15	298	1.129E-07	186
LOKIASV2_3079_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	0.135	297	237	8	304	3	277	8.530E-08	186
LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	0.145	296	227	16	311	69	334	6.408E-07	186
LOKIASV2_3079_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	0.155	290	199	9	298	107	342	6.408E-07	186
LOKIASV2_3079_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.156	288	203	16	303	4	245	8.968E-07	185
LOKIASV2_3079_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	0.150	296	218	16	311	12	269	1.335E-07	185
LOKIASV2_3079_ESMFold_hypothetical_protein	4im2-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4im2-assembly1.cif.gz_A Structure of Tank-Binding Kinase 1	0.134	300	243	6	305	1	282	1.067E-07	185
LOKIASV2_3079_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	0.144	314	259	7	320	5	308	4.606E-08	184
LOKIASV2_3079_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	0.136	290	195	9	298	104	330	4.094E-07	184
LOKIASV2_3079_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.148	296	218	16	311	13	269	5.729E-07	183
LOKIASV2_3079_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A p38alpha bound to pyrazolourea	0.153	305	246	16	320	23	313	7.626E-08	183
LOKIASV2_3079_ESMFold_hypothetical_protein	7sza-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7sza-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	0.180	168	122	20	187	20	169	8.915E-06	182
LOKIASV2_3079_ESMFold_hypothetical_protein	5ih6-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	5ih6-assembly1.cif.gz_A Human Casein Kinase 1 isoform delta (kinase domain) in complex with Epiblastin A derivative	0.137	305	233	2	306	1	271	3.460E-07	182
LOKIASV2_3079_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.150	296	224	16	311	18	281	1.412E-07	181
LOKIASV2_3079_ESMFold_hypothetical_protein	3uyt-assembly5.cif.gz_D-2	LOKIASV2_3079_ESMFold_hypothetical_protein	3uyt-assembly5.cif.gz_D-2 crystal structure of ck1d with PF670462 from P1 crystal form	0.135	291	213	16	306	6	252	1.187E-06	180
LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_B Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.153	295	228	16	310	29	298	2.338E-07	180
LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	0.142	296	222	16	311	64	323	7.581E-07	180
LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.156	314	241	16	329	17	303	1.976E-07	178
LOKIASV2_3079_ESMFold_hypothetical_protein	6cjw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6cjw-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in Complex With Inhibitor	0.129	287	222	16	302	13	268	1.061E-06	175
LOKIASV2_3079_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	0.130	325	213	2	326	1	246	1.580E-07	175
LOKIASV2_3079_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_B Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.142	331	254	3	299	11	341	5.729E-07	175
LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	0.135	301	229	16	316	70	335	1.003E-06	175
LOKIASV2_3079_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_B Crystal structure of STING CTT in complex with TBK1	0.134	300	254	6	305	3	296	3.660E-07	175
LOKIASV2_3079_ESMFold_hypothetical_protein	6pxn-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6pxn-assembly1.cif.gz_A Human Casein Kinase 1 delta Tau mutant (R178C)	0.146	305	236	2	306	1	277	1.061E-06	174
LOKIASV2_3079_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_A Crystal structure of STING CTT in complex with TBK1	0.139	296	249	10	305	8	297	2.615E-07	174
LOKIASV2_3079_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	0.164	289	219	16	304	16	278	4.606E-08	172
LOKIASV2_3079_ESMFold_hypothetical_protein	8q61-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8q61-assembly1.cif.gz_A Co-crystal structure of human AKT2 with compound 3	0.151	303	224	9	311	109	373	2.473E-07	172
LOKIASV2_3079_ESMFold_hypothetical_protein	4jl9-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	4jl9-assembly1.cif.gz_A Crystal structure of mouse TBK1 bound to BX795	0.129	300	260	7	305	1	300	4.579E-07	172
LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.135	288	227	16	303	30	293	2.090E-07	171
LOKIASV2_3079_ESMFold_hypothetical_protein	5ce3-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	5ce3-assembly2.cif.gz_D The Yersinia YopO - actin complex with MgADP	0.150	298	249	21	314	26	323	2.925E-07	171
LOKIASV2_3079_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.153	296	223	16	311	7	270	1.485E-06	169
LOKIASV2_3079_ESMFold_hypothetical_protein	6cqd-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	6cqd-assembly1.cif.gz_A Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)	0.159	296	218	16	311	16	275	2.078E-06	169
LOKIASV2_3079_ESMFold_hypothetical_protein	2vwb-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	2vwb-assembly1.cif.gz_A Structure of the archaeal Kae1-Bud32 fusion protein MJ1130: a model for the eukaryotic EKC-KEOPS subcomplex involved in transcription and telomere homeostasis.	0.198	171	111	22	192	328	467	1.055E-05	169
LOKIASV2_3079_ESMFold_hypothetical_protein	7szb-assembly2.cif.gz_C	LOKIASV2_3079_ESMFold_hypothetical_protein	7szb-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	0.203	168	120	20	187	20	170	1.651E-05	168
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.148	293	181	16	308	7	220	8.479E-07	165
LOKIASV2_3079_ESMFold_hypothetical_protein	7f2x-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7f2x-assembly1.cif.gz_A Crystal structure of MEK1 C121S mutant	0.144	295	225	16	310	27	290	1.404E-06	165
LOKIASV2_3079_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	0.139	289	232	16	304	11	281	1.756E-06	162
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.147	296	206	16	311	6	247	4.329E-07	161
LOKIASV2_3079_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	0.123	284	175	16	299	8	208	3.075E-06	160
LOKIASV2_3079_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.131	296	226	16	311	11	271	2.078E-06	156
LOKIASV2_3079_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	LOKIASV2_3079_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.134	296	215	16	311	11	259	3.253E-06	151
LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B	LOKIASV2_3079_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.153	296	187	16	311	8	229	6.370E-06	145
LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	LOKIASV2_3079_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	0.156	161	111	16	176	68	200	8.863E-05	129
LOKIASV2_3079_ESMFold_hypothetical_protein	4im3-assembly1.cif.gz_A-2	LOKIASV2_3079_ESMFold_hypothetical_protein	4im3-assembly1.cif.gz_A-2 Structure of Tank-Binding Kinase 1	0.111	300	234	6	305	1	264	5.385E-06	128
